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Abstract 
 In all human beings, when a pathogen enters the body, specialized cells are recruited 
to the site of inflammation, where, by different pathways and with the help of different 
macromolecules, they will destroy the invading microorganism. Past and ongoing research in 
this field is directed toward understanding the molecular and cellular regulation of this 
process. One way to destroy pathogens is the phagocytosis and subsequent intracellular 
killing, where macrophages play an important role, both by recognizing these pathogens and 
ingest them. To recognize pathogens, the macrophages have different receptors on their 
surface, for example Fc receptors (FcR) and complement receptors (CR), which bind to 
immunoglobuline G (IgG) or complement factor 3b (C3b) opsonized particles, respectively. 
After the macrophages have recognized a pathogen, several signalling processes regulate the 
uptake of the bacteria by the phagocytes. For example, non-receptor tyrosine kinases may be 
recruited to the plasma membrane, where they transmit signaling by cell surface receptors, 
controlling processes as diverse as the immune response, cell adhesion and neuronal cell 
migration. One member of this group of proteins is Pyk2, which can be involved in cell 
growth, shape and tumor invasion. In this study it is demonstrated that Pyk2 is recruited to the 
site of uptake, when a C3b-opsonized particle is recognized by the CRs on mouse 
macrophages. Specificity of the Pyk2 antibody, used for this study, was assured by in vitro 
assays. When a mouse-specific CD11b antibody was used to block the complement receptor 
3, the uptake and internalization of particles opsonized with complement, but not of particles 
opsonized with IgG, decreased significantly, proving that these particles were phagocytosed 
by the complement receptors. The functional role of Pyk2 in this issue has to be determined in 
further studies. Taken together, these results could improve the understanding of complement 
receptor mediated phagocytosis.  
 In a second approach, the Baculovirus expression was used to express functional 
human protein kinases in insect cells. Thus, different recombinant proteins were produced and 
purified, such as the Glutathione-S-Transferase (GST)-mFRNK-TAT and GST-Hck-kinase 
domain (KD). A Pyk2-KD and FAK-KD were also expressed by this system, purified, and 
successfully employed in in vitro kinase assays. Accordingly, this project covered all the steps 
necessary for the production of recombinant proteins and expression using the Baculovirus 
expression vector system. As the purified kinase domains showed activity, they will be useful 
tools for further biochemical in vitro studies. 
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Resumo 
 Em todos os seres humanos, quando um agente invasor entra no corpo, células 
especializadas são recrutadas para o sítio de inflamação onde, por diferentes vias e com a 
ajuda de diferentes macromoléculas, vão destrui-lo. Investigações nesta área são 
maioritariamente direccionadas para o entendimento da regulação molecular e celular deste 
processo. A fagocitose, processo pelo qual as partículas invasoras maiores que 0.5 μm de 
diâmetro são destruídas pelas células especializadas, tem um papel importante na imunidade 
inata, tanto por facilitar a remoção destas partículas como por iniciar a resposta imune 
adaptativa. É uma função fisiológica essencial, comum à maioria dos tipos de células 
eucarióticas e envolve a activação de complexas redes de sinalização. Como efetores críticos 
do sistema imunitário, os macrófagos usam processos de sinalização durante a adesão para 
concretizar muitas funções celulares essenciais, inclusivamente a fagocitose. Numerosos 
receptores fagocíticos estão presentes nos macrófagos, que se ligam directa ou indirectamente 
ao alvo. Destes receptores, os Fcγ e CRs são os mais estudados e exibem mecanismos 
diferentes de fagocitose e respostas celulares subsequentes que reflectem diferenças 
importantes nas suas vias de sinalização. Os Fc receptores (FcRs) servem de mediadores da 
fagocitose de partículas opsonizadas por IgG e os receptores de complemento (CRs) 
reconhecem as partículas opsonizadas com C3b/C3bi, componentes presentes no soro. Estes 
receptores juntam-se normalmente à volta da presa e induzem cascadas de sinalização 
intracelular que levam à activação e recrutamento de moléculas adaptadoras e de sinalização 
para sítios de ligação de partículas. A interacção das partículas opsonizadas com o 
complemento com CR3, desencadeia a imersão das partículas opsonizadas com o 
complemento e desempenha um papel importante na adesão celular, assim como na 
fagocitose. O papel da Pyk2, uma Proteína Tirosina Quinase não receptora, nas células da 
imunidade inata ainda não é claro. A Pyk2 não abriga os domínios SH2 ou SH3, mas contém 
vários sítios de ligação para diferentes proteínas de sinalização contendo SH2/SH3. Após a 
activação/autofosforilação dessa enzima em Tyr402, a Pyk2 pode ligar-se a proteínas do 
citoesqueleto (como a paxilina), de ligação (como a p130Cas), ou outras tirosina quinases 
(incluindo membros da família Src), que podem potencialmente impingir a Pyk2 numa 
variedade de vias de transdução de sinal. O sítio de autofosforilação da Pyk2 serve como um 
local de encaixe para o domínio SH2 da Src, permitindo-lhe alcançar uma conformação 
activa. Seguindo a activação, tanto a quinase Pyk2 como a Src funcionam em conjunto para 
activar a jusante moléculas de sinalização. Tem sido demonstrado que, juntamente com Src, a 
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Pyk2 funciona como um elo entre receptores acoplados à proteína G heterotrimérica e a via de 
sinalização da proteína quinase activada por mitógeno (MAP). Estudos anteriores mostraram 
que esta proteína é importante na activação dos macrófagos. Esta proteína foi mostrada ser 
uma molécula de sinalização intracelular crítica, integrando a estimulação de receptores de 
quemoquina e de factores de crescimento com várias vias a jusante. Anteriormente, a Pyk2 
tem sido associada a processos de migração e adesão, através de sua activação em resposta a 
diferentes quemoquinas e integrinas. Foram produzidos ratos deficientes em Pyk2 e a sua 
análise mostra que se desenvolvem normalmente, excepto por exibirem migração de 
macrófagos com defeito. Além disso, a Pyk2, tal como a FAK, podem ser reguladas pela 
activação de receptores de integrina. No entanto, a Pyk2 não está localizada em contactos 
focais, mas sim concentrada na região perinuclear das células. Neste contexto, foi então 
estudado se esta proteína, presente em diferentes processos de sinalização, era recrutada 
durante a fagocitose mediada por receptores complemento. Para os receptores complemento 
presentes nos macrófagos reconhecerem as partículas acopladas com IgM, e activarem a 
fagocitose, estas partículas foram incubadas com soro de ratos, opsonizando deste modo as 
partículas com o factor C3b, que é reconhecido pelos receptores complemento. Foram usadas 
para este estudo partículas acopladas com Albumina e GST, que não devem ser reconhecidos 
por nenhum receptor, IgG que é reconhecida por receptores Fcγ mas não CRs, IgM que sem 
incubação com soro não é reconhecida por nenhum receptor e depois de incubação com soro é 
reconhecida pelos CRs e iC3b, um factor do complemento que é directamente reconhecido 
pelos CRs. 
 Depois de testado, o anticorpo usado para a detecção da Pyk2 nas células foi 
considerado específico para a proteína, provando que todo o sinal detectado pelo mesmo se 
devia à Pyk2. Foram também realizados testes para a optimização do processo de infecção e 
coloração das células, assim como para o processo de fagocitose. Também foi provado que as 
partículas eram de facto fagocitadas pelos macrófagos, já que foram detectados fortes sinais 
depois de coloração com actina, já demonstrada ser necessária ao processo de fagocitose. O 
estudo iniciou-se com ensaios intra e extracelulares, para quantificar a percentagem de 
internalização e adesão das partículas às células. Foi provada a internalização das partículas 
acopladas com IgM e incubadas posteriormente com soro pelos receptores complemento, 
usando um anticorpo de CD11b M1/7015. Este anticorpo foi estudado anteriormente e foi 
demonstrado por bloquear os receptores complemento. Ao usar este anticorpo antes da 
infecção, as partículas deixaram de ser internalizadas. Foi investigado então o recrutamento 
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da Pyk2 durante a fagocitose mediada por receptores complemento e foi detectado um claro 
sinal, provando a participação desta proteína neste processo. Foi também detectado aumento 
da autofosforilação desta proteína em células lisadas, depois de infecção com IgG e IgM mais 
soro. 
 Num outro projecto, a Expressão por Baculovírus foi usada para a expressão e 
produção de proteínas funcionais. O Sistema de Expressão por Baculovírus usando vectores 
(BEVS) é o sistema de expressão eucariótica mais poderoso e versátil disponível. Neste 
sistema, vários genes Baculovírus não essenciais ao ciclo de vida na cultura de tecidos podem 
ser substituídos por genes heterólogos. Já que o genoma Baculovírus é geralmente muito 
grande para facilmente inserir genes estranhos, genes heterólogos são clonados em vectores 
de transferência. A co-infecção do vector de transferência e do DNA AcNPV dentro de 
células Spodoptera frugiperda (Sf) proporciona a recombinação entre os sítios homólogos, 
transferindo o gene heterólogo do vector de transferência para o DNA AcNPV. O Vírus de 
Poliedrose Nuclear Autographa californica (AcNPV) é o tipo de Baculovírus mais 
extensivamente estudada. A infecção de células Sf com o AcNPV resulta na paragem da 
expressão dos genes do hospedeiro, o que permite uma elevada taxa de produção de mRNA 
recombinante e de proteína. O vírus recombinante induz a expressão da proteína alvo 
recombinante e também infecta as células de insecto adicionais, resultando em vírus 
recombinantes adicionais. 
 Para a expressão da GST-Hck-KD e GST-mFRNK-TAT, o cDNA da GST foi 
primeiro clonado num vector de transferência, pVL1392. Depois de obtido o novo vector de 
transferência, o cDNA da Hk-KD e mFRNK-TAT foi clonado nesse novo vector, pVL1392 
N-term GST. Todas as construções foram sequenciadas e analisadas. As células Sf9 foram 
então co-infectadas com os vectores finais e o DNA BaculoGoldTM, levando à produção de 
Baculovírus recombinantes e expressão das proteínas heterólogas. O vírus recombinante foi 
amplificado por vários ciclos até o título do vírus ser maior ou igual a 2x108 pfu/mL e o título 
foi determinado indirectamente por coloração e subsequente análise por microscopia 
florescente. O mesmo foi então expresso, durante um tempo determinado por western blot, as 
células lisadas e as proteínas purificadas por FPLC. Depois de obtida a proteína, foi feita uma 
diálise de aproximadamente 18 horas e a concentração determinada por um gel SDS. Para 
determinar se as proteínas quinase eram activas, foram realizados ensaios de quinase in vitro. 
Foram testadas duas proteínas expressas, que demonstraram ser activas.  
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1. Introduction 
1.1 The immune system 
 Historically, immunity means protection from disease and, more specifically, 
infectious disease. The cells and molecules responsible for immunity constitute the 
immune system. Their collective and coordinated response to the introduction of foreign 
substances is called the immune response [1]. The immune system has evolved under 
tremendous selective pressure driven by pathogens. As a result, all multicellular 
organisms have developed the ability to recognize invading microbes and to eliminate 
them efficiently while avoiding massive damage to themselves. The problem with 
recognizing pathogens is their enormous variability and molecular heterogeneity, which 
is further aggravated by the high mutational rate characteristic of microorganisms and 
the use of a restricted number of receptors [2, 3]. This challenge has been partially met 
by the exploitation of conserved motifs on pathogens that are not found in higher 
eukaryotes. These motifs have essential roles in the biology of the invading agents, and 
are therefore not subjected to high mutation rates [3]. Vertebrates also have developed 
an additional way of dealing with the heterogeneity of pathogens by the way of the 
acquired immune system (see 1.1.1). 
The physiologic function of the immune system is defense against infectious 
microbes. However, even non-infectious foreign substances as well as endogenous 
proteins can elicit immune responses. Furthermore, mechanisms that normally protect 
individuals from infection and eliminate foreign substances are also capable of causing 
tissue injury and disease in some situations. Therefore, a more inclusive definition of 
immunity is a reaction to foreign substances, including microbes, as well as to 
macromolecules such as proteins and polysaccharides, regardless of the physiologic or 
pathologic consequence of such a reaction [1]. 
 
1.1.1 Innate and adaptive immune response 
Two general systems of immunity to infectious agents have been selected during 
evolution of vertebrates: the early reactions of innate immunity and the later responses 
of adaptive immunity (Figure 1) [1, 3, 4]. Both types of responses depend on the ability 
of the body to distinguish between own and foreign. Two categories of pathogens can 
be distinguished: those that occur primarily inside a host cell (all viruses, some bacteria, 
and certain protozoan parasites) and those that occur primarily in the extracellular 
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compartments of the host (most bacteria and other cellular pathogens) [5]. The essential 
difference between the two systems is the way by which they recognize microorganisms 
[4]. Innate immunity (also called natural or native immunity) consists of cellular and 
biochemical defence mechanisms to respond rapidly to infections. These mechanisms 
react only to microbes and not to non-infectious substances, and they respond in 
essentially the same way to repeated infections. The principal components of innate 
immunity are (1) physical and chemical barriers, such as epithelia and antimicrobial 
substances produced at epithelial surfaces; (2) phagocytic cells (neutrophils, 
macrophages) and NK (natural killer) cells; (3) blood proteins, including members of 
the complement system and other mediators of inflammation; and (4) proteins called 
cytokines that regulate and coordinate many of the activities of the cells of innate 
immunity. The mechanisms of innate immunity are specific for structures that are 
common to groups of related microbes and may not distinguish fine differences between 
foreign substances. Innate immunity provides the early lines of defence against 
microbes [1]. 
 
 
 
The adaptive immunity has been intensively studied with artificial antigens, such 
as haptens and foreign serum proteins, leading to a precise understanding of many of the 
cells, proteins, and genes involved [2]. The defining characteristics of adaptive 
immunity are exquisite specificity for distinct molecules and an ability to "remember" 
and respond more vigorously to repeated exposures to the same microbe. The adaptive 
immune system is able to recognize and react to a large number of microbial and non-
microbial substances. In addition, it has an extraordinary capacity to distinguish among 
different, even closely related, microbes and molecules, and for this reason it is also 
Figure 1 Innate and 
adaptive immunity. The 
mechanisms of innate 
immunity provide the initial 
defence against infections. 
Adaptive immune responses 
develop later and consist of 
activation of lymphocytes 
[6]. 
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called specific immunity. Sometimes it is also called acquired immunity, to emphasize 
that potent protective responses are "acquired" by experience [1]. Adaptive immunity is 
mediated by T and B lymphocytes bearing clonally-distributed antigen receptors [2]. 
Foreign substances that induce specific immune responses and are the targets of such 
responses are called antigens [1]. The specificities of these receptors are generated by 
somatic mechanisms, and therefore are not products of natural selection directed by 
pathogens. Rather, several random processes contribute to the generation of the 
specificities of antigen receptors. Consequently, each lymphocyte can have a receptor 
with unpredicted specificity. In particular, a mature peripheral lymphocyte can have a 
receptor specific for a self-antigen. Therefore, a signal received through the antigen 
receptor is not sufficient on its own for the activation of naive lymphocytes. Indeed, it 
has been well documented that a second so-called co-stimulatory signal is required for 
lymphocyte stimulation [2].  
Innate and adaptive immune responses are components of an integrated system 
of host defence in which numerous cells and molecules function cooperatively. The 
mechanisms of innate immunity provide effective defence against infections. However, 
many pathogenic microbes have evolved to resist innate immunity, and their elimination 
requires the powerful mechanisms of adaptive immunity. There are two important links 
between innate immunity and adaptive immunity. First, the innate immune response to 
microbes stimulates adaptive immune responses and influences the nature of the 
adaptive responses (Figure 2). Second, adaptive immune responses use many of the 
effector mechanisms of innate immunity to eliminate microbes, and they often function 
by enhancing the antimicrobial activities of the defence mechanisms of innate immunity 
[1]. The innate immune system is believed to have predated the adaptive immune 
response on several grounds [2]. 
Innate immunity is phylogenetically the oldest system of host defence, and the 
adaptive immune system evolved later. In invertebrates, host defence against foreign 
invaders is mediated largely by the mechanisms of innate immunity, including 
phagocytes and circulating molecules that resemble the plasma proteins of innate 
immunity in vertebrates. Adaptive immunity, consisting of lymphocytes and antibodies, 
first appeared in jawed vertebrates and became increasingly specialized with further 
evolution. 
 
4 
 
 
 
There are two types of adaptive immune responses, called humoral immunity 
and cell-mediated immunity, which are mediated by different components of the 
immune system and function to eliminate different types of microbes (Figure 3).  
 
 
Figure 3 Types of adaptive immunity. In humoral immunity, B lymphocytes secrete 
antibodies that prevent infections and eliminate extracellular microbes. In cell-mediated 
immunity, T lymphocytes either activate macrophages to kill phagocytosed microbes or CTLs 
directly destroy infected cells [7]. 
Figure 2 Innate and adaptive 
immunity. When a pathogen 
enters the body, mammals initially 
attempt to eliminate it by innate 
immunity. If the pathogen has 
previously infected (not correct, 
also in case of the first infection 
you will have an adaptive immune 
response) the organism, adaptive 
immunity then operates to 
specifically exterminate the 
returning invader [6]. 
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Humoral immunity is mediated by the secretion of antibodies by B lymphocytes 
(also called B cells). Antibodies recognize microbial antigens, neutralize the infectivity 
of the microbes, and target microbes for elimination by various effector mechanisms. 
Humoral immunity is the principal defence mechanism against extracellular microbes 
and their toxins because secreted antibodies can bind to these microbes and toxins and 
assist in their elimination. Therefore, immunization schemes that trigger pathogen- or 
toxin-specific antibodies belong to the most successful prophylactic treatments in 
medical history. Antibodies themselves are specialized, and different types of antibodies 
may activate different effector mechanisms. For example, some types of antibodies 
promote phagocytosis, and others trigger the release of inflammatory mediators from 
leukocytes such as mast cells. Cell-mediated immunity, also called cellular immunity, is 
mediated by T lymphocytes (also called T cells). Intracellular microbes and viruses 
survive and proliferate inside phagocytes and other host cells, where they are 
inaccessible to circulating antibodies. Defence against such infections is a function of 
cell-mediated immunity, which promotes the destruction of microbes residing in 
phagocytes or the killing of infected cells to eliminate reservoirs of infection [1]. 
 
1.2 Phagocytosis 
Phagocytosis, the process by which cells internalize particles larger than 0.5 μm 
in diameter, plays a critical role in innate immunity, both by facilitating the removal and 
killing of pathogens and by priming the adaptive immune response (Figure 4) [8, 9, 10, 
11, 12, 13]. It is an essential physiological function, common to most eukaryotic cell 
types [14] and involves the activation of complex signalling networks within the host 
cell [15]. As critical effectors of the innate immune system, macrophages use signaling 
processes during adhesion to accomplish many essential cellular functions, including 
phagocytosis [16]. 
Despite the complexity associated with different phagocytic mechanisms, a 
number of shared features follow: Particle internalization is initiated by the interaction 
of specific receptors on the surface of the phagocyte (some capable of direct 
recognition, the so-called pattern recognition receptors (PRRs), and others that 
recognize opsonins on the pathogens) with ligands on the surface of the particle [8, 10]. 
This leads to the polymerization of actin at the site of ingestion, and the internalization 
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of the particle via an actin-based mechanism. After internalization actin is shed from the 
phagosome, and the phagosome matures by a series of fusion and fission events with 
components of the endocytic pathway, culminating in the formation of the mature 
phagolysosome. Since endosome-lysosome trafficking occurs primarily in association 
with microtubules, phagosome maturation requires the coordinated interaction of the 
actin and tubulin based cytoskeleton [10].  
 
 
 
Numerous phagocytic receptors exist that can bind their target directly or 
indirectly through opsonins [13, 14]. Of these receptors, the opsonic Fcγ (FcγRs) and 
complements receptors (CRs) are the best described and exhibit different phagocytic 
mechanisms and subsequent cellular responses that reflect important differences in their 
signalling pathways [8, 17, 18, 19]. Ligand-bound receptors classically zipper around 
the phagocytic prey and induce intracellular signalling cascades that lead to the 
activation and recruitment of signalling and adaptor molecules at sites of particle 
binding. These locally assembled signalling complexes reorganize the actin 
cytoskeleton and regulate membrane dynamics underneath bound particles through the 
activation of Rho- and Arf-family GTP-binding proteins, respectively. According to the 
zipper model, phagocytosis of bound particles requires continuing ligation of 
phagocytic receptors around the whole phagocytic object, at least for spherical particles 
[10, 14]. The recognition mechanisms leading to phagocytosis occur either cellularly or 
humorally [10]. 
Fcreceptors (FcRs) mediate phagocytosis of IgG opsonized particles and 
complement receptors (CRs) recognize the particles opsonized with C3b/C3bi, 
Figure 4 Phagocytosis of 
bacteria by a neutrophil.  
a) Extensions of cytoplasm, 
called pseudopodia, surround 
the bacteria. b) Steps of the 
process to destroy the 
invading bacteria [5]. 
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components present in serum. Interaction of complement-opsonized particles with CR3 
triggers the engulfment of complement opsonized particles and plays important roles in 
cell adhesion, as well as in phagocytosis [20, 21]. 
 
1.2.1 Fc Receptor mediated phagocytosis 
Most of our understanding of the signaling pathways leading to phagocytosis in 
macrophages comes from studies of the FcRs [9]. In mammals, binding of 
immunoglobulins (Igs) to foreign particles leads to the prompt clearance of these 
particles from the organism. Igs act as opsonins, molecules that render the particle they 
coat more susceptible to the engulfment by phagocytic cells. The conserved Fc domain 
of the Igs is recognized by Fc receptors present on professional phagocytes, such as 
neutrophils and macrophages, and the opsonized particle is rapidly internalized. This 
internalization is characterized by a dramatic, actin-dependent extension of the plasma 
membrane around the particle and is followed by secondary activity, such as the 
production of reactive oxygen species and the release of inflammatory cytokines from 
the phagocyte [17]. Leukocyte Fc receptors promote the phagocytosis of opsonized 
particles and deliver signals that stimulate the microbicidal activities of the leukocytes. 
Fc receptors for different Ig heavy chain isotypes are expressed on many leukocyte 
populations and serve diverse functions in immunity. Of these Fc receptors, the ones 
that are most important for phagocytosis of opsonized particles are receptors for the 
heavy chains of IgG antibodies, called Fcγ receptors. There are three types of Fcγ 
receptors, which have different affinities for the heavy chains of different IgG 
subclasses and are expressed on different cell types [1, 10, 17, 22]. 
Phagocytosis of IgG-coated particles is mediated by binding of the Fc parts of 
opsonizing antibodies to Fcγ receptors on phagocytes. Therefore, the IgG subtypes that 
bind best to these receptors (IgG1 and IgG3) are the most efficient opsonins for 
promoting phagocytosis. Antibody molecules attached to the surface of a microbe or 
macromolecular antigen form multivalent arrays and are bound by phagocyte Fc 
receptors with much higher avidity than free circulating antibodies. Binding of multiple 
Fc receptors to antibody-coated particles leads to engulfment of the particles and their 
internalization in phagocytic vesicles. These phagosomes fuse with lysosomes, and the 
phagocytosed particles are destroyed in the phagolysosomes [1]. 
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Binding of opsonized particles to Fc receptors, particularly FcγRI, also activates 
phagocytes by virtue of signals transduced by the FcR γ chain. These signals result in 
the activation of several tyrosine kinases in the phagocytes, which stimulate production 
of various microbicidal molecules [1, 23]. 
 
1.2.2 Complement receptors mediated phagocytosis 
Complement-receptor mediated phagocytosis is morphologically distinct from 
that by FcRs, although both processes require actin polymerization. Complement-
opsonised particles „sink“ into the phagocyte. There is minimal membrane disturbance, 
and the internalization usually does not lead to an inflammatory response or oxidative 
burst [10]. Complement factors, present in serum, opsonize bacteria for phagocytosis by 
CRs on macrophages. Several receptors that participate in phagocytosis of complement-
opsonized particles, including CR1, CR3 and CR4 are expressed on macrophages and 
neutrophils [10, 14]. CR3 represents a member of leukocyte β2-integrin family and 
contains multiple binding sites, which are able to interact with a range of ligands [22]. 
Microbes on which the complement system is activated by the alternative or 
classical pathway become coated with C3b, iC3b, or C4b and are phagocytosed by the 
binding of these proteins to specific receptors on macrophages and neutrophils. C3b and 
C4b (the latter generated by the classical pathway only) bind to CR1, and iC3b binds to 
CR3 (Mac-1) and CR4. By itself, CR1 is inefficient in inducing the phagocytosis of 
C3b-coated microbes, but its ability to do so is enhanced if the microbes are coated with 
IgG antibodies that simultaneously bind to Fcγ receptors. C3b-and iC3b-dependent 
phagocytosis of microorganisms is a major defense mechanism against infections in 
innate and adaptive immunity [1]. 
Integrins on the surface of macrophages are linked to actin filaments by actin-
binding proteins such as vinculin and talin which are required for cytoskeletal 
rearrangement. While FcRs are constitutively active for phagocytosis, the CRs of 
residental peritoneal macrophages bind but do not internalize particles in the absence of 
additional stimuli [24, 25]. The activation of integrins is achieved via inside-out 
signaling, a process whereby the stimulation of cytokine and chemokine receptors 
activate intracellular signals (Figure 5). Those signals in turn regulate the avidity and/ or 
affinity of the integrins for the ligand, lateral mobility of integrins in the plasma 
membrane and subsequent binding of the cytoplasmic tails of integrins to cytoskeletal 
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proteins. Whilst the molecular details of inside-out signaling and the activation process 
of integrins are not precisely known, several potential elements in the mechanisms of 
activation have been identified. Cytokines (e.g. TNF-a and IFN-g) and phorbol esters 
(e.g. PMA) activate integrins via the activation of protein kinase C (PKC). PMA also 
induces an increase in phosphorylation of CD18. Examination of the cytoplasmic 
domains of CR3 and CR4 suggests several candidate sites for phosphorylation by PKC. 
PKC activation is associated with increased diffusion of the β2 chain of integrins. This 
suggests that phosphorylation of the β2 chain by PKC may serve as a regulatory 
mechanism for CR-mediated phagocytosis, and supports a role for β2 integrin 
phosphorylation by PKC that releases integrins from cytoskeletal constraints. Activation 
of integrins is known to be associated with a quantitative up-regulation of their 
functions. Upon activation, an integrin is thought to undergo a conformational change 
that enhances its ability to bind ligand. Following binding of the activated receptor to a 
Complement opsonized particle, CRs cluster and re-establish a firm link with the 
cytoskeleton. The few contact sites between the macrophage and Complement 
opsonized particle during the phagocytic process are rich in F-actin and cytoskeletal 
proteins such as vinculin, paxillin and a-actinin. CR-mediated phagocytosis results in 
the reorganization of polymerized actin at the site of ingestion and internalization of the 
opsonized particle. The signaling that induces actin polymerization and particle uptake 
by CR is not precisely known. 
CR-mediated phagocytosis activates RhoA, a member of the Rho family of 
small GTPases (Figure 5). Rho and other GTPases are central in the regulation of the 
actin cytoskeleton, and in particular, RhoA stimulates contractile processes. Activation 
of RhoA results in the bundling of actin filaments and clustering of integrins. Rho-
mediated signaling also promotes the assembly of stress fibres and focal adhesions, 
which regulate myosin filament formation and contractility. RhoA activation has been 
proposed to mediate integrin clustering at the site of ingestion, while regulating 
contractility of the actin cytoskeleton to allow the opsonized particle to sink inside the 
macrophage [25, 26]. 
The similarities in the roles of complement and Fc receptors in phagocytosis and 
inflammation raise the question of which is the more important effector mechanism of 
humoral immunity [1]. Also, IgM antibody-mediated protective immunity and 
pathologic reactions are dependent only on the complement system because IgM is an 
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efficient activator of the complement system but does not bind to leukocyte Fc receptors 
[1, 27]. To study complement mediated phagocytosis, there were used IgM coated 
particles which, therefore, were incubated with serum (which contains the complement 
components), leading to the recognition of these coated particles by complement 
receptors [28, 29, 30, 31]. 
 
Figure 5 A model for complement-receptor mediated phagocytosis. CRs are inactive at the 
cell surface. Cytokines released at a site of infection activate macrophages through cytokine 
receptors. This activates PKC and RhoA. PKC phosphorylates the β chain and activates 
integrins. RhoA, under the regulation of GEFs, stimulates downstream effectors to promote 
reorganization of the actin based cytoskeleton. This results in the bundling of actin filaments 
and the clustering of integrins. It is also possible that RhoA activation stimulates contractility, 
allowing the opsonized particle to sink into the cytosol of the macrophage [25]. 
 
1.3 Tyrosine Kinases 
 Proteins are the most diverse of all macromolecules, and each cell contains 
several thousand different proteins, performing a wide variety of functions [32], where 
each protein has a unique and defined structure that enables it to carry out a particular 
function [13]. 
 Protein kinases catalyze the transfer of the γ-phosphate group from ATP to the 
side chains of serine and threonine (protein-serine/threonine kinases) or tyrosine 
(protein-tyrosine kinases) residues. By contrast, protein phosphatases catalyze the 
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removal of phosphate groups from the same amino acids by hydrolysis. The combined 
action of protein kinases and protein phosphatases mediates the reversible 
phosphorylation of many cellular proteins. Frequently, protein kinases function as 
components of signal transduction pathways in which one kinase activates a second 
kinase, which may act on yet another kinase. The sequential action of a series of protein 
kinases can transmit a signal received at the cell surface to target proteins within the 
cell, resulting in changes in cell behaviour in response to environmental stimuli [32]. 
Protein-tyrosine phosphorylation is a mechanism for signal transduction that appeared 
with the evolution of multicellular organisms. Over 90 different protein-tyrosine kinases 
are encoded by the human genome. These kinases are involved in the regulation of 
growth, division, differentiation, survival, attachment to the extracellular matrix and 
migration of cells. Expression of mutant protein-tyrosine kinases that cannot be 
regulated and are constitutively active can lead to uncontrolled cell division and 
development of cancer.  
Protein tyrosine kinases can be divided into receptor and non-receptor classes by 
virtue of whether they possess or lack extracellular ligand-binding and transmembrane 
domains. On the basis of sequence similarity in the catalytic kinase domain and the 
presence of common structural motifs, numerous families of non-receptor tyrosine 
kinases have been defined. Non-receptor tyrosine kinases may be recruited to the 
plasma membrane, where they mediate cellular signaling by cell surface receptors 
lacking intrinsic protein tyrosine kinase activities, controlling processes as diverse as 
the immune response, cells adhesion and neuronal cell migration. For instance, 
members of the Src family of protein tyrosine kinases are activated in response to 
stimulation of growth factor receptors, different G-protein-coupled receptors, and many 
other extracellular stimuli [13, 33].  
One member of this group of kinases is the proline-rich tyrosine kinase (Pyk2, 
also designated RAFTK, CAK and CADTK). Pyk2 has an N-terminus with similarity to 
band 4.1 homology domain, a centrally located protein tyrosine kinase domain and two 
proline-rich regions at the C-terminus (Figure 6). 
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Figure 6 Non-receptor tyrosine kinase Pyk2. Proline-rich tyrosine kinase (Pyk2) has a central 
kinase domain, two proline-rich-regions (PRRs) and four tyrosine phosphorylation sites whereas 
the phosphorylation of Tyr402 and Tyr881 create binding sites for Src and growth factor 
receptor-bound 2 (GRB2), respectively. Pyk2 contains also a C-terminal focal adhesion 
targeting (FAT) domain that binds to paxillin. However, Pyk2 shows perinuclear distribution 
and is not strongly localized to focal contacts in many cells [34]. 
  
Proline-rich tyrosine kinase 2 is a non-receptor tyrosine kinase that is expressed 
in cells from neural, epithelial, and hematopoietic origin [35, 36, 37]. Pyk2 does not 
harbor SH2 or SH3 domains but contains several binding sites for different SH2/SH3-
containing signaling proteins. Following activation/autophosphorylation of this enzyme 
at Tyr402, Pyk2 may bind cytoskeletal proteins (like paxillin), linkers (like p130
Cas
), or 
other tyrosine kinases (including Src family members), which may potentially impinge 
Pyk2 in a variety of signal transduction pathways [35]. Also bind to Rho-GAP protein 
Graf and a LIM domain containing proteins, suggesting a role in regulation of the 
cytoskeleton and cellular morphology in response to extracellular stimuli [38, 39, 40]. 
The autophosphorylation site of Pyk2 serves as a docking site for the SH2 domain of 
Src [33], allowing it to achieve an active conformation. Following activation, both Pyk2 
and the Src kinases function in tandem to activate downstream signaling molecules [41]. 
It has been shown that, together with Src, Pyk2 functions as a link between 
heterotrimeric G-protein-coupled receptors and the mitogen-activated protein (MAP) 
kinase signaling pathway [33]. 
The function of Pyk2 in innate immune cells is not clear. Previous work has 
shown that Pyk2 is important in macrophage activation. Pyk2-deficient macrophages 
exhibit impaired adhesion and migration owing to decreased Rho GTPase, and PI3K 
activation after integrin ligation. Previous studies using Pyk2 inhibitors suggested that 
this enzyme is critical for superoxide production in human PMNs stimulated with TNF-
α. Furthermore, it was found that Pyk2 functions primarily in the integrin mediated 
signaling pathway and that Pyk2 deficiency results in reduced adhesion-mediated 
degranulation, which results in impaired host defense [41]. Also, studies with Yersinia 
(a genus of bacteria in the family Enterobacteriaceae) shown that Pyk2 function in 
Yersinia uptake by macrophages and, therefore, Pyk2 may be an integral part of the host 
response to Yersinia infections. Also in the same work, was found that Pyk2 
autophosphorylation becomes elevated upon Yersinia infection in FAK
-/-
 cells [42]. 
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Pyk2 is also shown to be a critical intracellular signaling molecule, integrating 
chemokine and growth factor receptor stimulation with a variety of downstream 
pathways, including Ras, mitogen-activated protein (MAP) kinase, protein kinase C and 
inositol phosphate metabolism [36, 43]. Previously, Pyk2 has been linked to migration 
and adhesion processes as shown by its activation in response to different chemokines 
and integrins. Pyk2–deficient mice have been generated and analysis shows they 
develop normally except for exhibiting defective macrophage migration. Similarly, B 
lymphocytes derived from Pyk2–deficient mice displayed decreased motility 
(background migration in the absence of stimuli) that was accompanied with decreased 
responsiveness to a variety of chemokines [43]. 
Pyk2 can be activated by a variety of extracellular signals that elevate the 
intracellular calcium concentration. In addition, treatment with phorbol esters or 
agonists of G-protein-coupled receptors leads to Pyk2 tyrosine phosphorylation. 
Moreover, Pyk2, like FAK, can be regulated by the activation of integrin receptors. 
However, Pyk2 is not localized in focal contacts but rather concentrated in the 
perinuclear region of cells [33]. 
 
1.4 Recombinant protein expression in insect cells 
The techniques developed in recombinant DNA technology have had an impact 
on every area of study in immunology. Genes can be cloned, DNA can be sequenced 
and recombinant protein products can be produced, providing components with which 
the structure and function of the immune system is studied [44]. These cloned genes can 
be transfected into cultured cells by several methods, expressing the recombinant 
proteins and purify them, afterwards [45]. It is known that insect cells, unlike bacteria, 
are capable of performing many of the processing events that are required for forming 
biologically active, foreign proteins [46]. Successful culture of insect cells requires a 
basic familiarity with insect cell physiology and general cell culture methods. The 
materials and methods for use with insect cell culture have evolved and contributed to 
the advancement of BEVS technology. The most common cell lines used for BEVS 
applications are Sf9, Sf-21, from Spodoptera frugiperda insect species, Tn-368 and 
BTI-TN-5B1-4, from Trichoplusia ni insect species. Of these, Sf9, a clonal isolate of 
the Spodoptera frugiperda cell line IPLB-Sf21-AE, is probably the most widely used. 
Sf9 was originally established from ovarian tissue of the fall armyworm. Although there 
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is significant scientific data on the characteristics of this Lepidopteran cell line, it 
remains to be confirmed whether it is the best line for virus or recombinant protein 
production. Ongoing research suggests that different insect cell lines may support 
varying levels of expression and differential glycosylation with the same recombinant 
protein [47]. 
  
1.4.1 The Baculovirus Expression Vector System 
 The Baculovirus Expression Vector System (BEVS) is one of the most powerful 
and versatile eukaryotic expression systems available. In this system, several 
Baculovirus genes non-essential in tissue culture life cycle (polyhedrin, p10, basic) may 
be replaced by heterologous genes [46, 48, 49, 50].  
Baculoviruses (family Baculoviridae) belong to a diverse group of large double 
stranded DNA viruses that infect many different species of insects as their natural hosts. 
Baculovirus strains are highly species-specific and are not known to propagate in any 
non-invertebrate host. The Baculovirus genome is replicated and transcribed in the 
nuclei of infected host cells where the large Baculovirus DNA (between 80 kb and 200 
kb) is packaged into rod-shaped nucleocapsids. Since the size of these nucleocapsids is 
flexible, recombinant Baculovirus particles can accommodate large amounts of foreign 
DNA. Autographa californica nuclear polyhedrosis virus (AcNPV) is the most 
extensively studied Baculovirus strain. Its entire genome has been mapped and fully 
sequenced. Infectious AcNPV particles enter susceptible insect cells by facilitated 
endocytosis or fusion, and viral DNA is uncoated in the nucleus [46]. 
Since the Baculovirus genome is generally too large to easily insert foreign 
genes, heterologous genes are cloned into transfer vectors. Co-transfection of the 
transfer vector and AcNPV DNA into Spodoptera frugiperda (Sf) cells, after growing 
the cells from mid- to late-exponential growth phase, allows recombination between 
homologous sites, transferring the heterologous gene from the transfer vector to the 
AcNPV DNA [48, 51] (Figure 7). AcNPV infection of Sf cells results in the shut-off of 
host gene expression allowing a high rate of recombinant mRNA and protein 
production. Recombinant virus induces recombinant target-protein expression and also 
infects additional insect cells thereby resulting in additional recombinant virus [46, 51]. 
The recombinant Baculovirus system for expression of heterologous proteins in insect 
cells was developed in the laboratories of Max Summers and Lois Miller. Development 
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of this expression system was based on observations of the wild-type baculovirus life 
cycle [51]. 
 
  
 
Choosing the right system for foreign gene expression can be particularly 
important in obtaining biologically active recombinant protein [46, 48]. Several unique 
features of the BEVS have made it the system of choice for many applications. Some 
advantages of using this system are: the use of insect cell, functional activity of the 
recombinant protein, high expression levels, capacity of large inserts, ease of 
purification, between others [46, 52]. The MOI (multiplicity of infection) and the time 
of infection are two parameters that are easily manipulated and that may be important in 
optimizing heterologous protein yields [50]. 
1.5 Aims of the project 
 Several studies have shown that Pyk2 may bind cytoskeletal proteins (like 
paxillin), linker proteins (like p130
Cas
), or other tyrosine kinases (including Src family 
members), which may potentially impinge Pyk2 in a variety of signal transduction 
pathways. Previous work has shown that Pyk2 is important in macrophage activation, 
Figure 7 Generation of 
recombinant proteins with 
Baculovirus Expression Vector 
System. The cDNA to be expressed 
is cloned into a transfer vector 
(pVL1392) under the control of the 
polyhedrin promoter. This vector is 
co-transfected with linearized 
baculovirus DNA into the host 
insect cells. Through homologous 
recombination, the cDNA of interest 
replaces the polyhedrin cDNA [51]. 
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but the overall function of this protein in innate immune cells is still unclear. Pyk2 was 
also shown to be a critical intracellular signaling molecule, integrating chemokine and 
growth factor receptor stimulation with a variety of downstream pathways, including 
Ras, mitogen-activated protein (MAP) kinase, protein kinase C and inositol phosphate 
metabolism. As this protein is expressed in macrophages, and can be activated during 
phagocytosis, in the present project the aim was to know if this protein is recruited 
during complement receptor-mediated phagocytosis. First of all, the conditions should 
be improved, to further have a reliable Pyk2 staining and an efficient uptake of 
complement-opsonized particles. Pyk2 staining in macrophages, after activation of 
complement-mediated phagocytosis can show afterwards, if this protein is recruited or 
not. 
In between, another project took place. The major aim was to express 
recombinant proteins with a Baculovirus expression vector system in insect cells Sf9. 
This way, active proteins could be produced, which can be further used in in vitro as 
well as in vivo studies. The TAT sequence was already shown to induce the uptake of 
proteins in vivo and FRNK (FAK-related non-kinase), can be used for studies of FAK, 
which is implicated in numerous cellular processes, including cell migration, 
differentiation, survival and proliferation. Thus, a recombinant protein bearing the TAT 
sequence, GST and FRNK wanted to be produced, to further investigate if the TAT 
sequence allows the uptake of FRNK and, if it this happens, this recombinant protein 
could be used for studies in vivo. Additionally, the kinase domain of Hck should be 
expressed as a GST-fusion protein in Sf9 and the kinase activity of the purified protein 
should be verified using an in vitro kinase assay. 
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2. Results 
 In the present work is separated in two different projects. Firstly, the analysis of 
the recruitment of Pyk2 in macrophages during complement receptor-mediated 
phagocytosis is presented. Secondly, the recombinant expression of different proteins in 
Sf9 insect using the baculovirus expression vector system is shown. The proteins were 
afterwards purified for further use in in vitro and in vivo assays. 
 
2.1 Analysis of the recruitment of Pyk2 in macrophages after establishing IgG-
versus complement-mediated opsono-phagocytosis assay 
 To analyze the recruitment of Pyk2 in during complement receptor-
mediated phagocytosis, first of all the conditions had to be optimized to have a reliable 
Pyk2 staining and an efficient uptake of complement-opsonized particles. As 
macrophages are hard to transfect, HEK 293T cells were used. HEK 293T cells were 
transfected with Pyk2-HA, Pyk2-myc or the empty vector as a negative control. A 
western blot analysis of the transfected cells was made and it shows positive 
transfection for the two constructs (Figure 8). After staining, the cells were analyzed at 
the microscope. The results shows that the transfection worked, and as the cells had the 
same sites stained can be concluded that the Pyk2 antibody is specific for the protein 
(Figure 9).  
Figure 8 Transfection of 293T cells 
with Pyk2 constructs. 293T cells 
were transfected with the indicated 
constructs and were lysed 48 h later. 
Expression of the constructs was 
analyzed by western blotting using a 
Pyk2 AB 1:400 and an appropriate 
secondary antibody. Normally the 
size of the constructs should be 
nearly the same, as the single HA-
tag compared to single myc-tag are 
similar in size but some difference is 
detected. This can be explained by 
the 6xmyc tag at the N-terminus of 
Pyk2 compared to the 2xHA tag of 
the HA-Pyk2 construct. 
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After this assay, the best procedure to fix and permeabilize the cells was determined. 
During this assay, the cells were stained for Pyk2 (1:50 in blocking solution) and four 
approaches were made: 
1. 4% PFA 15 min at RT to fix the cells and ice-cold Acetone 10 min at -20ºC to 
permeabilize. 
2. 4% PFA 15 min at RT to fix the cells and 0.4% Triton X-100 in PBS ++ 3 min at 
RT to permeabilize. 
3. 4% PFA 15 min at RT to fix the cells and 0.4% Saponin 10 min at RT to 
permeabilize. 
Figure 9 Analysis of Pyk2 expression by transfected cells using immunofluorescence. 293T 
cells were stained after fixation with 4% PFA and permeabilization with 10% FCS and 0.2% 
Saponin in PBS
++
. The Pyk2, myc and HA AB were diluted 1:200 in blocking solution. The 
secondary antibodies used were a goat-anti-mouse Cy3 antibody for HA and myc and a goat-anti-
mouse Cy2 antibody for Pyk2. Thus, the Pyk2 can be distinguished from the HA and myc as the 
Cy3 fluorescence is detected by a TRITC channel and the Cy2 fluorescence is green detected by a 
FITC channel. Scale bar 10 μm. 
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4. MeOH ice-cold 5 min at -20ºC to fix the cells and 0.4% Triton X-100 in PBS ++ 
3 min at RT to permeabilize. 
After staining, the cells were analyzed using a fluorescence microscope (Figure 10). 
For all samples the same exposure times were used to allow comparison of the staining. 
It can be seen that the best way to fix and permeabilize the cells was the second 
approach, as with the same conditions for all approaches, this one has the highest signal 
in the green channel. The staining procedure is described in the methods section. 
 
 
It is described in the literature that macrophages need to be pre-activated before 
infection, and only this way bound particles will be phagocytosed by the complement 
receptors [14, 19]. To pre-activate the macrophages normally PMA or LPS are used 
[53]. Beside this, it was unclear which coating procedure assists maximal stimulation of 
the cells. In thus, Raw macrophages were seeded on fibronectin (1 µg/mL) or 0.1% of 
gelatine and maintained 2 hours at 37ºC. After this time, the cells were washed once 
with DMEM with 0.5% h.i. FCS and stored in this medium at 37ºC. The next day, the 
medium was supplemented with 150 ng/mL of PMA or 300 ng/mL of PMA in different 
wells and with 1 mM HEPES. The range of PMA concentration was as in the literature 
Figure 10 Analysis of fixation 
and permeabilization 
parameters for Pyk2 
immunostaining. Raw 
macrophages were seeded on 
Poly-L Lysin/Fibronectin, get 
fixed and permeabilized as 
indicated and stained for Pyk2 
using appropriate antibodies. 
Scale bar 10 μm. 
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[6, 11, 19, 53]. The cells were then incubated for 15 min at 37ºC and then analyzed at 
the microscope, taking pictures every 5 minutes for one hour. The movement of the 
cells and the spreading was analyzed by ImageJ (data not shown). It was seen that the 
cells spread better on Fibronectin, however, on Gelatine the cells seems to be more 
activated as they displayed increased migration. The cells not pre-activated showed only 
marginal movement. Therefore, to analyze the recruitment of Pyk2 in the cells during 
phagocytosis it was chosen to use Gelatine for coating and 200 ng/mL of PMA to pre-
activate the cells, before infection. 
It is well known that Actin plays an important role during phagocytosis [17, 54, 
55] and there are made recent advances in this field, mostly related to FcR and CR3 
[55]. Thus, the cells were infected with coupled beads and filamentous actin was stained 
to see if these beads were in fact phagocytosed by the cells (Figure 11). The beads were 
coupled with Albumin and GST, negative controls for phagocytosis as they don´t bind 
to receptors present in macrophages, IgG that, as described before, are internalized by 
the FcRs which allows have a positive control for phagocytosis, IgM that is showed to 
be internalized by the CRs after incubation with serum that contains the complement 
components, and iC3b that is a complement component and the macrophages has a iC3b 
receptor which recognize opsonized particles with this component. It was seen in all 
samples (except for Albumin as expected), that Actin was recruited to sites of infection. 
These results indicate that the beads are in fact being phagocytosed by the macrophages, 
which allows us to proceed to the analysis of Pyk2. 
The Pyk2 staining did not showed any clear recruitment of this protein during 
phagocytosis (Figure 11). The analysis of Pyk2 continued with all conditions described 
before, and after three unsuccessful attempts was made an assay to see if the beads were 
in fact internalized by the cells. To this, the coupled beads were stained before infection 
with CFSE 1:1000 in PBS and after infection with antibodies against the coupled 
proteins to distinguish between intracellular beads from adhered, extracellular beads 
(Figure 12) (This procedure is described in the methods section). 
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Figure 11 Actin recruitment during phagocytosis. Raw macrophages were incubated for 20 
min with the indicated beads and fixed. Samples were stained for actin and Pyk2 staining. The 
intensity, exposure time and signal amplification in both channels were adjusted so that in the 
sample without staining there was no signal. Scale bars 10 μm. 
 
The IgM beads were opsonized with complement components by incubating 
with mice serum at 37ºC for 1 h. The quantification of the first intra- and extracellular 
assay revealed the internalization of IgG and IgM with serum beads, as well as the IgM 
beads alone (Figure 13). The IgG beads are internalized by the Fc receptors [1, 10, 11, 
31, 56] and the IgM with serum beads should be internalized by the CRs. But as we can 
see an IgM beads internalization it was not sure that the CRs are active for IgM with 
serum beads. 
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Figure 12 Internalization of coated latex beads by mouse macrophages. All the beads were 
stained with CFSE before infection and after infection and fixation the beads were stained 
again, and as there was no permeabilization only the extracellular beads should be stained. A 
streptavidin-Cy3 or Cy3 antibody was used, depending if the beads were biotinylated or not 
during CFSE staining (only the beads without antibody against the protein coupled were 
biotinylated, as the Albumin beads). The intra- and extracellular beads were distinguished 
afterwards. The beads in the cells were counted after analysis at the microscope, where the 
CFSE stained beads were detected with a FITC channel and the Cy3 stained beads with a 
TRITC channel. In this case the time of infection was 60 min. Scale bar 20 μm. 
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The serum components present in IgM beads will activate the complement 
system and those beads should be recognized by the complement receptors and 
phagocytosed. The IgM beads only should not be internalized as they can not activate 
the CR, neither the FcR, but in Figure 13A a significant internalization of these beads 
can be seen. An hypothesis to this internalization was the FCS used in the medium. 
Thus, another assay was made, now with serum free medium (DMEM with 0.5% BSA). 
The cells were seeded the day before infection with normal medium and before 
infection the medium was changed. The serum incubation with IgM beads and the 
staining of the beads was done as before. To analyze whether the PMA really assisted 
the internalization of the particles, approaches with and without pre-activation with 
PMA were made. It was observed that PMA activation appears to induce the 
internalization of more beads in the IgM samples, so it was always used in the next 
experiments. Between the samples with IgM beads in normal and serum free medium, 
there was not a big difference. After 10 min there is more internalization with normal 
medium but after longer time points the internalization appears not to change 
B 
Figure 13 Internalization of coated latex beads by mouse macrophages. The cells were 
infected with MOI 40 at 37°C. After the indicated infection time the reaction was stopped with 
ice-cold PBS and washed with PBS. The cells were then fixed with PFA and the beads were 
stained (after blocking), as described before (Figure 12). Two different views of the results are 
presented where in A one can see the % of intracellular beads in each sample and in B the total 
and intracellular beads per cell in each sample. 
24 
 
significantly (Figure 14). Thus, another hypothesis was that the IgM particles can be 
internalized by the Fc receptors or another pathway. 
 
 
 
A 
B 
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To investigate whether the uptake of IgM with serum beads is in deed based on 
CR mediated internalization a CD11b antibody against CRs was used to block them. It 
was shown previously that the CD11b antibody M1/70.15 can block the complement 
Figure 14 Intra- and extracellular assay with serum free medium. The cells were pre-activated 
or not with PMA and infected with MOI 40 at 37ºC. After the indicated infection time, the 
reaction was stopped with ice-cold PBS and washed with PBS. The staining procedure and the 
analysis by microscopy were as before (figure 12). As before, two different views of the results 
are presented. In A and B are the % intracellular beads with and without PMA, respectively, and 
in C and D the total and intracellular beads per cell with and without PMA, respectively. 
 
C 
D 
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receptors in macrophages using 10 µg/mL (10 min before infection), at room 
temperature [57, 58]. These conditions were used and the CD11b antibody was added 
during PMA activation, before infection.  
In the first assay using the blocking procedure (data not shown) the IgG beads 
were blocked by the antibody. As the antibody was eluted in PBS with sodium azide, 
perhaps the inhibitory effect was due to the sodium azide, as this antimicrobial agent is 
toxic to most organisms as well it blocks the cytochrome electron transport system [59]. 
Therefore, the antibody was purified with a column, washing three times with PBS 
only, 10-15 min each time at 14000 rpm. After this purification, the concentration of the 
antibody was determined by a spectrophotometer (NanoDrop) and a new assay was 
made. To have a negative control for the blocking with CD11b antibody, an isotype-
matched antibody was used (Rat IgG2b). These antibodies were also used to couple 
beads to have a better positive and negative control for the internalization, as the CD11b 
beads are only internalized by the CRs. To be sure that the Fc domains present in the 
antibodies were not exposed to be recognized by Fc receptors during infection, the 
beads were first coupled with Protein G that is shown to have great affinity to the Fc 
domains of IgG subclass 2b [60]. 
The IgG beads were not blocked as expected. Surprisingly, also the uptake of 
IgM only beads was not blocked. The IgM with serum beads are now blocked by the 
CD11b antibody but not by the Rat IgG2b (isotype from the CD11b). This shows that 
the IgM with serum beads uptake is really mediated by the complement receptors. The 
CD11b beads are internalized as the IgM with serum beads, which demonstrate that the 
complement receptors are active in the cells, and the RatIgG2b beads are a better 
negative control as they are less internalized than Albumin and GST beads (Figure 15). 
After proving the complement receptor mediated internalization of the IgM with 
serum beads, the recruitment of Pyk2 to sites of infection was investigated again. Now, 
the tissue plates were centrifuged with the beads after infection for 3 min at 500xg, as in 
the intra- and extracellular assay, and the serum starvation was used. As expected no 
recruitment was found during the phagocytosis of Albumin, GST and Rat IgG2b beads. 
For IgG beads there was seen a recruitment in some cases. An approach was made 
blocking the cells with CD11b antibody before infection with IgM with serum beads 
and there was no recruitment of Pyk2, supporting that the recruitment of Pyk2 during 
the phagocytosis of these beads is due to the phagocytosis by the complement receptors. 
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The IgM with serum and CD11b beads show a strong recruitment of Pyk2 during 
phagocytosis (Figure 16). 
 
 
 
 
 
 
 
 
Figure 15 Intra and extracellular assay with CD11b blocking. The cells were seeded the previous 
day and the medium was changed to DMEM + 0.5% h.i. FCS. After the time of infection the cells 
were washed, fixed and the beads were stained as before. These results were obtained after 60 min of 
infection using MOI 40. In A is represented the % intracellular beads and in B the total and 
intracellular beads per cell. 
 
A 
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In the beginning of the work iC3b coated beads were used, but there was no 
clear recruitment, as for the other beads, and in the intra- and extracellular assay there 
was no internalization of the beads (data not shown). As now the conditions of the 
assays are stable, and we see clear recruitment, another approach with these beads was 
made. As before, no recruitment was found during the phagocytosis of Albumin and 
GST beads as expected. For IgG beads there was seen a clear recruitment. The IgM with 
serum beads have a clear and strong signal, as well as the iC3b beads (Figure 17). 
To analyze the internalization of the iC3b beads, a new intra- and extracellular 
assay was made. Was seen that after 30 min of infection, the internalization of iC3b 
much intense than with the negative control beads (Figure 18). Also, after blocking the 
CRs with the CD11b antibody before cited, the internalization of these beads, as the 
IgM with serum beads, used as positive control, decreased significantly. Thus, it was 
clear that these beads also were internalized by the CRs as expected. 
Figure 16 Recruitment of Pyk2 during CD11b or IgG-mediated phagocytosis. The cells 
were infected with MOI 15, centrifuged and after 30 min the reaction was stopped with ice-cold 
PBS. The cells were fixed, permeabilized, blocked, and stained for Pyk2 (1:50). It was used a 
Cy2 antibody to visualize the beads in the FITC channel and the pictures of Pyk2 recruitment 
were taken to have no signal in the non-stained cells. Scale bar 10 μm. 
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Figure 17 Recruitment of Pyk2 after infection with iC3b beads. The cells were infected with 
MOI 15, centrifuged and after 30 min the reaction was stopped with ice-cold PBS. The cells were 
fixed, permeabilized, blocked, and stained for Pyk2 (1:50). A Cy2 antibody was used to visualize 
the beads in the FITC channel and the pictures of Pyk2 recruitment were taken to have no signal 
in the non-stained cells. Scale bar 10 μm. 
31 
 
 
 
 
 
 
 
  
 
Taken together the results reveal that Pyk2 is recruited during complement-
mediated phagocytosis. Consequently, the next question is which functional role Pyk2 
plays in this process. As Pyk2 needs to be phosphorylated to be active, the 
phosphorylation of Pyk2 in macrophages after infection with coupled beads was 
determined. It was seen, after infection with IgG and IgM with serum beads, the 
Figure 18 Intra- and extracellular assay with iC3b beads. The cells were seeded the previous day 
and the medium was changed to DMEM + 0.5% h.i. FCS. After the time of infection the cells were 
washed, fixed and the beads were stained as before. These results were obtained after 30 min of 
infection using MOI 40. In A is represented the % intracellular beads and in B the total and 
intracellular beads per cell. 
 
A 
B 
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increase of Pyk2 phosphorylation in the samples without PMA activation (Figure 19). 
The cells were seeded and infected as before, and after the time of infection they were 
lysed with Ripa buffer, and the lysates were analyzed by Western blot. Pyk2 
phosphorylation was seen with the α-PTyr AB at around 120 KDa. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19 Test the phosphorylation of Pyk2. The cells were seeded as before, the medium was 
changed in the day before and the cells were infected for 30 min at 37ºC after PMA activation or 
not and centrifugation. Three antibodies were used to analyze the phosphorylation of the proteins 
in the samples (α-PTyr 1:1000), the amount of cell lysate added to the gel (α-Tubulin 1:1000) and 
the Pyk2 (1:400). 
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2.2 Recombinant expression in Sf9 insect cells 
With the help of Baculovirus expression system, four distinct proteins were 
expressed in insect Sf9 cells and then purified. First, the GST-Hck-KD and GST-
mFRNK-TAT constructs needed to be cloned by modifying the commercial vector with 
a GST-encoding sequence before combining that with the other sequences. In the case 
of Pyk2-KD and FAK-KD, the cDNAs had already been inserted in the transfer vector 
pVL1392. 
 
2.2.1 Cloning of the cDNA into a Baculovirus   transfer 
vector 
For expression of GST-Hck-KD and GST-mFRNK-TAT, 
first the cDNA of GST was cloned into the transfer vector 
pVL1392. For amplification of the cDNA by PCR, two primers 
were used at which the 5’-primer had a BglII restriction site and 
the 3’- primer a NotI restriction site. A hot start PCR was carried 
out with these primers and the template plasmid which contains 
the GST cDNA. After the PCR, products were separated using a 
1.4 % agarose gel (Figure 20). The samples containing the two 
most intensive bands were combined and purified using the 
QIAquick PCR Purification kit from Qiagen through the 
column. 
Subsequently, the insert and the transfer vector were 
digested with the same enzymes (BglII and NotI). The resulting 
fragments were separated in an agarose gels (Figure 21) and isolated using the 
QIAquick GelExtraction Kit from Quiagen. 
Therefore, the two fragments (vector and insert) were ligated with T4 ligase, 
transformed into E. coli Nova blue and plated on LB plates with ampicillin and 
incubated over night. Colonies that grown were transferred to new LB plates and the 
next day plasmids were isolated. To ensure which clones had the insert, they were 
digested with ScaI. Figure 22 shows the six clones digested and non-digested and the 6
th
 
clone shows the two expected bands of 4690 bp and 5621 bp. The clone was sequenced 
to be sure that there were no mutations in the DNA and was frozen for long-term 
storage. 
Figure 20 Amplification of GST 
cDNA by PCR. In all cases the 
expected band at about 700 bp is 
detected. 
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 In the next step, the cDNA of Hck-KD and mFRNK-TAT had to be cloned in 
the new transfer vector pVL1392 N-term GST. As before, the cDNA was amplified 
with two primers each by PCR in which the 5’-primers had a NotI recognition site and 
the 3’-primers had an EcoRI recognition site. A hot start PCR was carried out with these 
primers and the template plasmid which contains the HcK-KD cDNA and the mFRNK-
TAT cDNA. After PCR, products were separated on a 1.4 % agarose gel (Figure 23). 
The two most intensive bands were combined and purified using the QIAquick PCR 
Purification kit from Qiagen through the column. 
Figure 21 Digestion of: 
A) pVL1392 transfer vector with BglII 
and NotI. In the two cases a major band 
of approximately 9000 bp is detected.  
B) GST cDNA with BglII and NotI. In 
the two cases a major band of 
approximately 700 bp is detected.  
 
 
 
Figure 22 Verification of the pVL1392-GST clones by restriction digest. In the first rows 
there is the empty vector of pVL1392 as negative control of digestion where with ScaI the 
pVL1392 is linearized. Clone six shows the two expected bands of about 4690 bp and 5621 bp 
after ScaI digestion.. 
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Subsequently, the insert and the transfer vector pVL1392 N-term GST were 
digested with the same enzymes. The resulting fragments were separated in agarose gels 
(Figure 24) and isolated using the QIAquick GelExtraction Kit from Quiagen. 
 
 
 
 
Therefore, the two fragments (vector and insert) were ligated and transformed as 
before. For the Hck-KD construct, plasmids of 30 clones were isolated and analyzed by 
colony PCR. The figure 25 shows nine clones only and the clone 9 is supposed to be 
positive, as well as clones 12 and 27 (data not shown). To ensure that the clones had the 
insert, they were digested with BglII and EcoRI. The figure 26 shows the digestion of 
the three clones and the empty vector as a negative control. Only clone 27 shows the 
expected bands. Therefore, the clone was sequenced to be sure that there were no 
mutations in the DNA and was frozen for long-term storage. For the mFRNK-TAT 
Figure 23 Amplification of mFRNK-TAT 
cDNA and Hck-KD cDNA by PCR. All 
approaches had the band size expected, for 
mFRNK-TAT about 1100 bp and for Hck-
KD about 850 bp. 
 
Figure 24 Digestion of: 
A) mFRNK-TAT and Hck-KD with NotI 
and EcoRI. In the two cases for mFRNK-
TAT a major band of approximately 1100 
bp is detected and in the two cases for 
Hck-KD  major band of approximately 
850 bp is detected. 
B) pVL1392 N-term GST with NotI and 
EcoRI. In the two cases a major band of 
approximately 10300 bp is detected.  
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construct the clones were digested with XhoI, one positive was chosen, sequenced and 
frozen as for the other constructs. Four positive clones were obtained for this construct 
(Figure 27). 
 
 
 
Figure 25 PCR products. As seen before, 
the Hck has a band size of about 850 bp. In 
the clone 9 this band can be seen as in the 
positive control.  
 
Figure 26 Verification of the clones by 
restriction digest. In the first column pVL1392 
N-term GST was loaded as negative control. 
There is a band of about 700 bp as expected for 
the digestion with XhoI. In the other columns are 
the three clones positive for PCR but only one has 
the characteristic band for the digestion of the 
construct with Hck-KD at about 1500 bp.  
 
Figure 27 Verification of the clones by restriction digest. 
In the first column, pVL1392 N-term GST was loaded as a 
negative control. There is a band of about 10000 bp as 
expected for the digestion with XhoI. The other columns 
show four clones and all are positive, as they all have the two 
characteristic bands of about 8000 and 3300 bp with the 
digestion with XhoI. 
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2.2.2 Production of recombinant baculoviruses 
Sf9 cells were co-transfected with the final transfer vectors and BaculoGold
TM
 DNA, 
leading to the production of recombinant baculoviruses and expression of the heterologous 
proteins. 
 
2.2.3 Amplification and indirect titer determination of recombinant baculoviruses 
A titer is a way of expressing concentration. Titer testing employs serial dilution to 
obtain approximate quantitative information. The titer corresponds to the highest dilution 
factor that still yields a positive reading, and, in this case, the viral titer is the lowest 
concentration of virus that still infects cells. The recombinant virus was amplified through 
several cycles until the titer was about 2x10
8
 pfu/mL. After each amplification round, the titer 
was determined indirectly by antibody staining and subsequent fluorescent microscopy 
analysis. Sf9 cells were seeded in 96 well-plates and after the cells attach to the plate, were 
infected with different dilution factors. The cells were afterwards stained, after an incubation 
time of 2 days at 27ºC, using an antibody which recognizes the C-terminal epitope tag added 
to each protein (see plasmid maps). Thus, only the cells expressing the protein were counted 
to the titer determination. Not-transduced cells were used to adjust background level in the 
Cy3 channel (Figure 28). Afterwards, samples with less than 10% of infected cells were 
chosen for quantification and six pictures were taken (three for each well). The cells were 
counted and from the ratio of transduced to non-transduced cells the titer was determined, as 
explained in the methods section. In each amplification, the viral titer typically increases an 
order of magnitude, for example, from 1x10
7
 to 1x10
8
. 
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2.2.4 Test of the best time to express the protein 
Before starting the large scale expression of the proteins, it was necessary to know 
which time for expression for each protein was better to obtain the highest yield. The Sf9 cells 
were transduced and after 24, 48 and 72 hours they were harvested and lysed. An additional 
approach remained non-transduced cells and served as a negative control. The samples were 
analyzed for target protein expression by SDS-PAGE and subsequent Western blotting with 
the appropriate antibodies for each protein or a NEF antibody that recognizes the C-terminal 
domain present in all produced proteins. Using a HRP-coupled secondary antibody the 
primary antibody was visualized. For GST-Hck-KD was chosen 72 h to express the protein as 
the characteristic band for the protein at about 56 kDa is more intense, showing more amount 
of protein (Fig. 29A).  For GST-mFRNK-TAT was chosen 48 h, as this sample showed a 
clear large amount of the protein, comparing with the 24 h (Figure 29B). 
 
Figure 28 Indirect baculovirus titer determination by antibody staining. The bottom 
row shows pictures of non-transduced cells where no signal is observed in the Cy3 channel. 
In the top row infected cells appear red in the Cy3 channel due to the expression of the 
heterologous protein. This example is from baculovirus titer determination carrying the 
Pyk2-KD construct and the chosen dilution factor was 10
-5
. Scale bar 50 μm. 
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2.2.5 Expression and purification of the proteins 
For expression of the protein in large scale, ten 10 cm cells culture dishes, each one 
with 8.8x10
6
 cells, were transduced with MOI 4, incubated at 27ºC for the best time of 
expression and lysed afterwards.  
The lysates were then purified by Fast Protein Liquid Chromatography (FPLC). The 
columns were always equilibrated with the lysis buffer used. For Pyk2-KD and FAK-KD, the 
lysates were loaded onto a HisTrapFF crude column and washed with washing buffer. 
Subsequently, a washing step was followed by 5% elution buffer (500 mM imidazole) in 
washing buffer and finally the column matrix-bound protein was eluted. For GST m-FRNK-
TAT and GST-Hck-KD another column was used (GSTrapFF). In this case the column was 
washed with 50 mM Tris pH 8 and 10 mM Glutathion. Figure 30 shows the different 
purification profiles for Pyk2-KD, GST-mFRNK-TAT and GST-Hck-KD, where the green 
lines represents the concentration of the elution buffer over time and the red line the 
absorption (A280), indicating the protein concentration, over time.  
Figure 29 Analysis of target protein expression for: 
A) GST-Hck-KD with NEF antibody (up) and GST antibody (down). Sf9 cells were 
transduced or left uninfected (negative control) and lysed after 24, 48 and 72 hours. After 
72 hours we have a clearly band at about 56 KDa, time used, afterwards, during 
expression. 
B) GST-mFRNK-TAT with GST antibody. Here we don’t see clearly the bands but 
comparing the 48 hours with 24 hours we see a clear expression. In this case the 48 hours 
were chosen for expression. In this test expression was chosen to lyse the cells with 
2xSDS. Perhaps the lysis with lysis buffer is better as we can see in the blot for GST-Hck-
KD. 
 
 
40 
 
 
 
 
 
 
 
 
41 
 
Figure 30 Profiles from the purification by FPLC of: 
A) Pyk2-KD. Here we can see a peak at about 75 min correspondent to the time of elution of 
the protein. This tells us that the purification worked. 
B) GST-mFRNK-TAT. Here we can see a peak at about 85 min correspondent to the time 
of elution of the protein which tells us that the purification worked. 
C) GST-Hck-KD. Here we can see a peak at about 85 min correspondent to the time of 
elution of the protein which tells us that the purification worked. 
 
 
 
 
After the elution all fractions were taken and analyzed for target protein by SDS-
PAGE. As controls, the lysate was applied to the gel, followed by the flow through and the 
fractions from the washing steps. Figure 31 shows the different fractions analysis for FAK-
KD, GST-m-FRNK-KD and GST-Hck-KD. The fractions containing the protein are clearly 
seen and those which have the highest staining were combined for dialysis.  
C 
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After dialysis the concentration of the proteins was determined, before the aliquots 
were frozen in liquid nitrogen and stored at -80 ºC. The concentration of the purified protein 
was determined using a polyacrylamide gel, adding different concentration of BSA as control 
and the purified protein. After separation and coomassie staining, the band of the protein was 
compared with those of the BSA standard. As the concentration of BSA, in all approaches 
Figure 31 Fractions analysis for: 
A) FAK-KD. As shown in the figure there are three clear bands for FAK-KD at around 29 
KDa. As we can see in the picture, this protein is not so pure, reason why the profile of 
the purification of this protein is not shown. As the purification did not work so well, 
these fractions were stored after dialysis but noted to be not pure. 
B) GST-mFRNK-TAT. In this case there are again three bands at around 66 KDa that 
belongs to this protein. The fractions 4 and 6 were combined for dialysis and the fraction 
5 was combined with Rhodamine (1:1000) 30 minutes at room temperature and then 
dialysed. Thus, the protein gets already color and can be visualized by microscopy 
without being necessary to stain. 
C) GST-Hck-KD. Here the two bands at about 56 KDa in the four and five fractions are not 
clear has they are in the gel. As the Fraction 5 had some contaminants, the fractions were 
dialyzed separately. 
 
 
43 
 
Figure 32 Quantification of: 
A) Pyk2-KD. For this protein we see a band from the fraction 6 and 7 close to the band of 
BSA 0.1 µg/µL and more intense than for BSA 0.05 µg/µL. Therefore, it’s assumed that 
the concentration is about 0.075 µg/µL. For the other fractions the band is not so clear in 
the picture but it’s half of the band correspondent to BSA 0.05 µg/µL so the concentration 
is around 0.025 µg/µL. 
B) FAK-KD. For this protein we see a band of the fraction 8 and 9 more intense than for 
BSA 0.1 µg/µL so the concentration should be 0.15 µg/µL. For fraction 7, the band 
appears to be the double of the band correspondent to BSA 0.1 µg/µL. Therefore the 
concentration is 0.2 µg/µL. 
C) GST-mFRNK-TAT. For this protein we can’t really see clear bands but it’s clear that the 
band correspondent to the fraction 5 with Rhodamine is half of the band for BSA 0.05 
µg/µL. Therefore the concentration is 0.025 µg/µL. For the other fractions the band is not 
clear enough for quantification. 
D) GST-Hck-KD. Again the bands are not clear in this image, but was seen that for fraction 
4 the concentration is 0.01 µg/µL and for fraction 5 0.02 µg/µL.  
was known, the same staining of bands indicates the concentration of the purified protein. 
Figure 32 shows the different protein concentration determination gels for Pyk2-KD, FAK-
KD, GST-mFRNK-TAT and GST-Hck-KD. 
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2.2.6 Verification of the functionality of the expressed proteins 
To determine whether the kinase proteins were active, an in vitro kinase assay was 
performed. The procedure was conduced as described in the methods section. Two 
approaches were made with two different substrates (Table 1 and 2), and two kinase proteins 
were tested, FAK-KD and Pyk2-KD. 
Table 1 Amounts of reagents for the in vitro kinase assay using GST-p130
Cas
 substrate. 
 Substrat (GST-p130Cas) µM ATP 
Kinase 
[µl] 
Substrat 
[μL] from 
0.1 μg/μL 
solution 
Kinase-
Buffer 
[µl] 
1 
Substrat only (GST-
p130Cas) 
0 0 2 Up to 30 μL 
2 Kinase only (FAK-KD) 0 4 0 Up to 30 μL 
3 Kinase only (Pyk-KD) 0 4 0 Up to 30 μL 
4 Substat +K (FAK-KD) 0 4 2 Up to 30 μL 
5 Substat +K (PYk2-KD) 0 4 2 Up to 30 μL 
6 FAK-KD +ATP 100 4 0 Up to 30 μL 
7 Pyk2-KD + ATP 100 4 0 Up to 30 μL 
8 Substat +ATP 100 0 2 Up to 30 μL 
9 Substat +FAK-KD +ATP 100 4 2 Up to 30 μL 
10 Substat +Pyk2-KD +ATP 100 4 2 Up to 30 μL 
 
Table 2 Amounts of reagents for the in vitro kinase assay using GST-FAK-substrate. 
 Substrat (GST-FAK) µM ATP Kinase [µl] 
Substrat 
[μL] from 
0.1 μg/μL 
solution 
Kinase-
Buffer 
[µl] 
1 Substrat only (GST-FAK) 0 0 2 Up to 30 μL 
2 Kinase only (FAK-KD) 0 4 0 Up to 30 μL 
3 Kinase only (Pyk-KD) 0 4 0 Up to 30 μL 
4 Substat +K (FAK-KD) 0 4 2 Up to 30 μL 
5 Substat +K (PYk2-KD) 0 4 2 Up to 30 μL 
6 FAK-KD +ATP 100 4 0 Up to 30 μL 
7 Pyk2-KD + ATP 100 4 0 Up to 30 μL 
8 Substat +ATP 100 0 2 Up to 30 μL 
9 Substat +FAK-KD +ATP 100 4 2 Up to 30 μL 
10 Substat +Pyk2-KD +ATP 100 4 2 Up to 30 μL 
 
 After analysis by western blot, it was seen that both kinase proteins tested were active 
in vitro, with an antibody which detects phosphorylated Tyrosins (α-PTyr 1:1000). To see the 
substrate in the samples a GST antibody (1:1000) was used and the kinases a NEF antibody 
(1:5000) (Figure 33). 
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Figure 33 In vitro Kinase Assay. In A and C are presented the results for GST-p130
Cas
 substrate 
and in B, D and E for GST-FAK-substrate. Glutathione beads were used in this last substrate to 
fix to the substrate, and, after washing, remove the kinase from the substrate. 
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3. Discussion 
3.1 Analysis of the recruitment of Pyk2 in macrophages during complement receptor-
mediated phagocytosis 
 Pyk2, a non-receptor tyrosine kinase, is known to bind to cytoskeletal proteins, linkers 
and other tyrosine kinases, which may potentially impinge Pyk2 in a variety of signal 
transduction pathways [33]. 
During complement receptor-mediated phagocytosis, it has not been demonstrated yet 
that Pyk2 is recruited and functionally involved. Nevertheless, it was shown before that in 
response to Fc receptor-mediated phagocytosis, Pyk2 tyrosine phosphorylation is stimulated, 
and this kinase has been implicated in other processes involving reorganization of the 
cytoskeleton, such as migration and adhesion [20] as well as macrophage activation [39]. Also 
studies with Yersinia have shown an increase of Pyk2 autophosphorylation upon infection in 
FAK
-/-
 cells. Thus, Pyk2 may be an integral part of the host response to Yersinia infections 
[40]. Pyk2 was also shown to be a critical intracellular signaling molecule and has been linked 
to migration and adhesion processes analyzed by its activation in response to different 
chemokines and integrins [34, 41].  
Additionally, Pyk2 binds to the Rho-GAP Graf and LIM domain containing proteins, 
suggesting a role in regulation of the cytoskeleton and cellular morphology in response to 
extracellular stimuli [36, 37, 38]. CR-mediated phagocytosis activates RhoA, a member of the 
Rho family of small GTPases. Rho and other GTPases are central in the regulation of the actin 
cytoskeleton, and in particular, RhoA stimulates contractile processes. Activation of RhoA 
results in the bundling of actin filaments and clustering of integrins. Rho-mediated signaling 
also promotes the assembly of stress fibres and focal adhesions, which regulate myosin 
filament formation and contractility. RhoA activation has been proposed to mediate integrin 
clustering at the site of ingestion, while regulating contractility of the actin cytoskeleton to 
allow the opsonized particle to sink inside the macrophage [novo, RhoA]. As Pyk2 may play a 
role in regulation of the cytoskeleton, binding to Rho, which is known to be important in CR-
mediated phagocytosis, Pyk2 may be also important in CR-mediated phagocytosis. As this 
protein is implicated in different signaling processes, the up regulation of the macrophages 
during this process can be done by the help of Pyk2. 
Thus, it is important to study this kinase to have a better understanding of this small 
part of the immune system. In this aim, it was shown in the present work that Pyk2 is 
recruited during complement receptor-mediated phagocytosis (Figures 15 and 16). 
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 To analyze Pyk2 localization during complement receptor-mediated phagocytosis 
mouse macrophages were used. These cells are known to phagocyte microbes when innate 
immune response is activated. PMA was used to activate the macrophages, as it was shown 
before that macrophages without stimulation or pre-activation are not able to phagocyte the 
microbes but only to bind them [14, 19]. To have a direct and certain ingestion of particles by 
complement receptors Polystyrene beads were coupled with IgM, which were incubated with 
serum to be opsonized with complement components that are, during infection, recognized by 
the complement receptors [26, 27, 28, 29]. Furthermore, a direct complement component, 
iC3b, was used to label the Polystyrene beads. 
 To have a reliable Pyk2 staining and an efficient uptake of complement-opsonized 
particles, the conditions were optimized. The Pyk2 antibody was shown to be specific for this 
protein, after transfect the cells with Pyk2 constructs and immunfluorescence staining (Figure 
7). As showed before, actin plays an important role during many phagocytosis processes [17, 
52, 53]. Thus, the actin was stained after infecting the macrophages with coupled beads, and it 
was seen a clear recruitment of Pyk2 at the site of ingestion. As the staining of Pyk2 in the 
beginning did not show any recruitment (data not shown), the internalization of the particles 
was studied. After staining the intra- and extracellular beads after different times of infection, 
it was shown that the beads were internalized efficiently (Figures 12 and 13). Also, to be sure 
that the opsonized IgM particles were internalized by the complement receptors, the 
complement receptor antibody CD11b M1/70.15 was used which is known to block 
complement receptor-mediated uptake [55, 56]. Only the particles opsonized with 
complement were blocked, clarifying the internalization of these particles by the complement 
receptors (Figure 14). During these assays, some unexpected results were obtained. The IgM 
beads which were not incubated with serum should not be internalized by any receptors in 
macrophages. Surprisingly, there was a significant internalization of these beads. It was 
proved that those beads were not internalized by the complement receptors but the pathway 
that IgM beads take after infection is not clear. After proving the phagocytosis of the beads by 
the complement receptors, except the negative controls and the IgG beads, the Pyk2 was 
stained to investigate whether this kinase was recruited during complement-mediated 
phagocytosis. In the first assays (data not shown), it was discovered that the best time to study 
the recruitment of Pyk2 was 30 min infection. After infecting the macrophages using all the 
optimized conditions and stain the Pyk2, a clear recruitment was observed (Figures 15, 16). It 
is also shown a clear recruitment of Pyk2 during Fc receptor-mediated phagocytosis, using the 
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IgG beads that were already shown to be internalized by this pathway in macrophages [1, 10, 
11, 29, 54]. In previous studies in this group, it was shown that Pyk2 does not play a 
functional role during Fc receptor-mediated phagocytosis (A.-K. Fuchs, unpublished data). 
However, the recruitment of Pyk2 during this process was not analyzed.  
To further investigate if Pyk2 is activated during complement-mediated phagocytosis, 
after proving the recruitment the phosphorylation of Pyk2 was investigated. The cells were 
infected, lysed and analyzed by western blotting. A clear phosphorylation of Pyk2 was seen in 
all samples and after infection with IgG particles and IgM opsonized with complement 
particles, an increase of this phosphorylation was observed (Figure 18). 
 
3.2 Expression of kinase domains in Sf9 insect cells 
 Using the Baculovirus Expression Vector System (BEVS), the kinase domains of Pyk2 
and FAK were expressed with a His-tag and the kinase domain of Hck and FRNK were 
expressed as GST-fusion proteins. The goals were the kinase domains for further testing in 
vitro and use these proteins for in vitro analysis. To express these proteins, a polyhedrin 
transfer vector was used, so that the gene is expressed under the polyhedrin promoter. It is 
known that the polyhedrin promoter is more active in the late stages of the infection cycle 
[44] and thus, 72 hours for expression were normally assumed, that the amount of expressed 
protein after infection time was highest. Nevertheless, a test expression was always made to 
be sure of the best time to express these proteins. All expressed proteins were purified by 
FPLC, which demonstrates success, except for FAK-KD where the purified protein had some 
contaminants (Figure 30). Accordingly, for this protein the use of additional purification 
could be useful, as there are more bands corresponding to other proteins. For the GST-tag 
purified proteins there are other bands to, which can be due to protein degradation during 
expression, as the bands exhibit the size of GST, Hck and FRNK alone. The flow through and 
wash fractions show bands corresponding to the protein. Perhaps a portion of the target 
protein in the purification under the conditions used got lost, but this could not be clarified by 
the Coomassie staining. This could be tested by a Western blot, using an antibody against the 
protein and seeing if these bands really belong to the target protein. After Dialysis, the 
concentration was determined and a test for the activity of the kinase domain was performed. 
The concentrations for Pyk2-KD, FAK-KD, GST-mFRNK-TAT and GST-Hck-KD were 0.1 
mg/mL, 0.175 mg/mL, 0.025 mg/mL and 0.015 mg/mL, respectively (Figure 31), and in an in 
vitro kinase assay it could be shown that the isolated kinase domains of Pyk2 and FAK are 
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catalytically active (Figure 32). The two substrates used in this assay showed a good 
performance, however the GST-FAK-substrate has the same size as the kinases and it is 
necessary the use additional steps to get ride of the kinases. 
 
3.3 Outlook 
The aims of this study were accomplished, as the recruitment of Pyk2 during 
complement receptor-mediated phagocytosis was seen and this protein was phosphorylated 
during this process. The functional role of Pyk2 in this process is not clear yet, but further 
studies will be necessary to clarify this issue. The next steps with this protein can be the use of 
knock down macrophages to analyze if this protein is required for complement receptor-
mediated phagocytosis. Also the use of Pyk2 inhibitors during complement mediated 
phagocytosis, displacing Pyk2 from their functions. 
Since the expression and purification of the proteins were successful, following further 
investigations can be made, as the use of GST-mFRNK-TAT to see the uptake of FRNK 
(FAK non-related kinase), which can be used to study the well-known FAK, using the TAT 
sequence which is known to increase the uptake of proteins in vitro. Since its initial discovery 
as a substrate and binding partner for the Src oncogene, a role for FAK in cancer has been 
speculated. Thus, the regulation and role of this kinase in biological processes, important for 
the pathogenesis of cancer, may be important. Also, it is often desirable to attempt to measure 
and to modulate the activity of the protein kinases and phosphatases responsible for a given 
phenotypic change.  Protein kinase can be used for more understanding in protein 
phosphorylation pathways and kinase signaling cascades. 
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4. Material 
4.1 Cells 
Table 3 Cells. 
 
Raw 264.7 
 
Sf9 
 
HEK 293T cells 
 
 
Mouse leukaemic monocyte macrophage cell line 
 
Spodoptera frugiperda clonal isolate 9 
 
human epithelial kidney cells 
 
4.2 Medium 
4.2.1 Medium for agar plates 
Table 4 Medium for agar plates. 
 
LB Medium 
 
 
LB agar plates 
 
 
 
Refreezing medium 
 
1% w/v Tryptone; 0.5% w/v yeast extract; 0.5% w/v NaCl; pH 
7.0 with NaOH (autoclaved) 
 
1% w/v Tryptone; 0.5% w/v yeast extract; 0.5% w/v NaCl; 10 
mM MgCl2; 1.2% w/v Agar-Agar; pH 7.0 with NaOH 
(autoclaved) 
 
Refreezing medium 50% v/v LB medium; 50% v/v Glycerol 
(50%) 
 
 
 4.2.2 Medium for cell culture 
Table 5 Medium for cell culture. 
 
Raw 264.7 maintenance 
 
 
Raw 264.7 freezing 
 
 
Sf9 maintenance 
 
 
 
Sf9 freezing 
 
HEK 293T cells maintenance 
 
 
DMEM 4.5 g/L Glucose + 10% v/v h.i. FCS (foetal bovine 
serum) 
 
DMEM 4.5 g/L Glucose with 10% DMSO and 20% v/v h.i. 
FCS. 
 
12.76 g IPL-41 Medium + 0.175 g NaHCO3 (pH 6.0) + 10% 
FCS + 2% Yeastolate + 2% Lipid concentrate + 1% 
Penicillin/Streptomycin 
 
Sf9 maintenance medium with 10% DMSO and 20% FCS. 
 
DMEM 4.5 g/L Glucose + 7.5% v/v CS (calf serum) 
 
4.3 Antibodies 
 4.3.1 Primary antibodies 
Table 6 Primary antibodies. 
Antigen Name 
Monoclonal/ 
Polyclonal, Imunogen 
Species Supplier 
51 
 
ATβ2 ATβ2 Monoclonal Rat AG Hauck 
CD11b M1/70.15 Monoclonal Mouse ImmunoTools 
c-myc 9E10 Monoclonal Mouse Santa Cruz 
c-Src SRC-2 Polyclonal Rabbit Santa Cruz 
GST B-14 Monoclonal Mouse Santa Cruz 
HA F-7 Monoclonal Mouse Santa Cruz 
His H3 Monoclonal Mouse Santa Cruz 
IgG2b 
Rat IgG2b 
control 
Monoclonal Mouse ImmunoTools 
NEF α-NEF Hybrid clone Mouse AG Hauck 
PTyr α-PTyr Monoclonal Mouse AG Hauck 
Pyk2 H-102 Polyclonal Rabbit Santa Cruz 
Tubulin α-Tubulin Monoclonal Mouse 
Development 
studies Hybidoma 
Bank/Joseph 
Frankel 
 
 4.3.2 Secondary antibodies 
Table 7 Secondary antibodies. 
Name Supplier 
Biotin-SP-conjugated AffiniPure Goat Anti-Mouse IgG 
 
Biotin-SP-conjugated AffiniPure Goat Anti-Mouse IgM 
 
Cy2-conjugated AffiniPure Goat Anti-Rabbit IgG 
 
Cy3-conjugated AffiniPure Goat Anti-Mouse IgG 
 
Cy3-conjugated AffiniPure Goat Anti-Rabbit IgG 
 
Cy5- conjugated AffiniPure Goat Anti-Mouse IgG 
 
HRP-conjugated AffiniPure Goat Anti-Mouse IgG 
 
HRP-conjugated AffiniPure Goat Anti-Rabbit IgG 
 
Rhodamine Red conjugated goat-α-Rat IgG 
Jackson 
 
Jackson 
 
Jackson 
 
Jackson 
 
Jackson 
 
Jackson 
 
Jackson 
 
Jackson 
 
Jackson 
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4.3.3 Antibodies independent staining reagents 
Table 8 Antibodies independent staining reagents. 
Name Supplier 
 
Alexa-Fluor546-Phalloidin 
 
Hoechst 
 
CFSE 
 
FITC-Streptavidin 
 
TAMRA 
Rhodamine (TRITC)-Streptavidin 
 
Molecular Probes 
 
Molecular Probes 
 
Molecular Probes 
 
ICN-MPBiomedicals 
 
Molecular Probes 
Jackson 
 
4.4 Enzymes, proteins and complement components 
4.4.1 Enzymes 
Table 9 Enzymes. 
Name Supplier 
Pfu-Polymerase 
 
Phosphatase 
 
Restriction Enzymes 
 
T4 Ligase 
 
Taq-Polymerase 
 
Trypsin-EDTA (1x) 
 
AG Hauck 
 
NEB 
 
Fermentas or NEB 
 
AG Hauck 
 
AG Hauck 
 
PAA Laboratories 
 
 4.4.2 Proteins and complement components 
Table 10 Proteins and complement components. 
Name Supplier 
Albumin from chicken egg white 
 
Anti-Sheep Red Blood Cell Monoclonal Antibody-
Ascites (IgM) 
 
Complement iC3b, Human 
 
FAK-KD 
 
Fibronectin 
 
GST 
 
His-Pyk2 
Sigma 
 
Cedarlane 
 
 
Calbiochem 
 
AG Hauck 
 
BD Bioscience 
 
AG Hauck 
 
AG Hauck 
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Poly-L-Lysin 
 
Recombinant Protein G from E. coli 
 
Sigma 
 
ZYMED Laboratories 
 
4.5 Inhibitors 
Table 11 Inhibitors. 
Name Target Supplier 
Leupeptin (Acetyl-L-leucyl-L-
argininal hemisulfate) 
 
PMSF 
(phenylmethanesulfonylfluoride) 
Serine, cysteine and threonine 
proteases 
 
Serine proteases 
Calbiochem 
 
 
Applichem 
 
4.6 Primers 
Table 12 Primers. 
Name Sequence Template Plasmid 
GST pVL 1392 
BglII_sense 
 
GST pVL 1392 
NotI_anti 
 
Hck-KD pVL 1392 
EcoRI_anti 
 
 
Hck-KD pVL 1392 
NotI sense_neu 
 
mFRNK EcoRI 
anti 
 
 
 
mFRNK NotI 
sense 
 
5’-ACGAGATCTACCATGTCCC- 
CTATACTAGGTTATTG 
 
5’-ACTGCGGCCGCACGATCCA- 
CGCGGAACCAG 
 
5’-ACTGAATTCTTACCCATTCT- 
TGAAATATTCAGGCCCACGGT-
TTTTCCAGCAGCG 
 
5’-ACTGCGGCCGCGGGAACG- 
ACGGGCTCTG 
 
5’-ATCGAATTCTTAGCGGCGG- 
CGCTGGCGGCGTTTCTTGCG- 
GCCGTAGCCGCCGCGTGTCT- 
GCCCTAG 
 
5’-ACTGCGGCCGCGAATCCAG- 
AAGACAGGCTAC 
 
 
pGEX-4T-1 
 
 
 
 
human Hck 
cDNA 
 
 
 
 
 
 
pAAVFRNK 
 
 
 
 
 
 
 
pVL 1392 
 
 
 
pVL 1392 
 
pVL 1392 N-
term GST 
 
 
 
 
 
pVL 1392 N-
term GST 
 
 
 
 
 
4.7 Plasmids 
Table 13 Plasmids. 
Vector Inserts Cloning Strategy or 
source 
 
pOTB7 
 
pAAVFRNK 
 
pcDNA3.1(+) Hygro  
 
 
Hck 
 
FRNK-HA 
 
Myc-Pyk2WT 
 
 
AG Hauck 
 
AG Hauck 
 
AG Hauck 
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pcDNA31Hygro (empty 
vector) 
 
pEGFP C1 (positive for  
transfection) 
 
pGEX-4T-1 
 
pLP 
 
pLPS-3'EGFP  
 
pVL 1392 
 
pVL 1392 N-term GST 
 
 
 
 
 
pVL 1392 
 
 
 
pVL 1392  
 
 
 
pVL 1392 N-term GST  
 
 
 
 
 
 
GFP 
 
 
 
 
hPyk2WT 
 
CEACAM3WT 
 
 
 
mFRNK-TAT  
 
 
 
 
 
His-Hck-KD-Nef  
 
 
 
N-term GST  
 
 
 
Hck-KD-Nef 
AG Hauck 
 
 
AG Hauck 
 
 
AG Hauck 
 
AG Hauck 
 
AG Hauck 
 
AG Hauck 
 
Restriction digest with 
NotI/EcoRI and ligation 
with pVL 1392 His-Hck-
KD-NEF NotI/EcoRI 
digested 
 
Restriction digest with 
NotI/EcoRI and ligation 
with PCR product 
 
Restriction digest with 
NotI/BglII and ligation with 
PCR product  
 
Restriction digest with 
NotI/EcoRI and ligation 
with pVL 1392 His-Hck-
KD-NEF NotI/EcoRI 
digested  
 
4.8 Media and Buffer 
Table 14 Media and Buffer. 
Name Preparation 
Anode buffer (5x)  
 
 
Birnboim-Doly P1 
 
 
 
Birnboim-Doly P2 
 
 
Birnboim-Doly P3 
 
 
Blocking buffer 
 
Blotto 
125 mM Tris-Base 
200 mM 6-aminohexanacid pH 9.4 
 
50 mM Tris/HCl 
10 mM EDTA 
100 mg/mL RNAse A 
 
0.2 mM NaOH 
20% w/v SDS 
 
3 M potassic acetate 
pH 5.5 with acetic acid 
 
10% v/v h.i. CS in PBS
++ 
 
2% w/v BSA 
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Borate buffer 
 
 
Carbodiimide 
 
 
Carbonate buffer  
 
Cathode buffer (5x) 
 
Coomassie Stain 
 
 
 
Destain  
 
 
DNA-Ladder (1 kb Marker)  
 
dNTPs [20 mM] 
 
 
 
 
 
Dialysis Buffer 
 
 
 
 
Ethidium bromide 
 
FACS buffer 
 
 
 
CFSE 
 
GEBS 
 
 
 
 
H2O2 solution 
 
HBSS (Hanks’ Balanced Salt 
Solution) 
 
Kinase Buffer 
 
 
0.05 %w/v Sodium azide  
in 1x TBS-T 
 
0.2 M borate buffer prepare by adding 1 M NaOH to 
boric acid until pH 8.5 
 
2% N-(3-Dimethylaminopropyl)-N’-ethyl-carbodiimide 
hydrochloride in 0.1 M MES buffer 
 
0.1 M Na2CO3 in 0.1 M NaHCO3 until pH 9.6 
 
125 mM Tris-Base pH 10.4 
 
25% v/v Isopropanol 
10% v/v Pure acetic acid 
3% w/v coomassie 
 
45.5% v/v Methanol 
9.1% v/v Pure acetic acid 
 
1 kb DNA-Ladder in 6x loading dye solution 
 
20 mM dGTP 
20 mM dATP 
20 mM dCTP 
20 mM dTTP 
in ddH2O 
 
20 mM Tris HCl, pH 7.5 
0.5 M NaCl 
0.1 mM β-Mercaptoethanol 
5 L total 
 
10 mg/mL EtBr 
 
5% heat inactivated FCS 
0.1% Sodiumazide 
in 1x PBS 
 
4 mg/mL CFSE in DMSO 
 
20% w/v Glycerol 
0.5% w/v Sarkosyl  
50 mM EDTA 
0.05% bromphenol blue 
 
30% v/v H2O2 
 
PAA Laboratories 
 
 
20 mM HEPES; pH 7,3 
10 mM MgCl2 
10 mM MnCl2 
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Lysis buffer for Sf9 cells (1) 
 
 
 
 
 
 
 
 
Lysis Buffer for Sf9 cells (2) 
 
 
 
 
 
 
 
 
MES buffer 
 
PBS (10x) 
 
 
 
 
PBS
++ 
 
 
 
PFA 4%  
 
 
Pfu-buffer  
 
 
 
 
PMA (Phorbol 12-myristate 13-
acetate) 
 
Poly-L-Lysin 
 
RIPA-buffer 
 
 
 
 
 
 
 
 
150 mM NaCl 
10% Glycerol 
 
25 mM Tris pH 7.5 
1 mM EDTA 
0.33% Tween 20 
500 mM NaCl  
100 µM PMSF 
1 mM β-Mercaptoethanol 
5 µg/mL Leupeptin 
1 mM NaVO3 
 
10 mM Tris pH 7.5 
130 mM NaCl 
0.5% Triton X-100 
10 mM NaF 
10 mM NaPi 
10 mM NaPPi 
100 µM PMSF 
5 µg/mL Leupeptin 
 
0.1 M MES in water pH 5.2-6 
 
1.37 M NaCl  
26.8 mM KCl 
14.7 mM KH2PO4 
78.1 mM Na2PO4 
 
0.9 mM Ca
++ 
(CaCl2) 
0.5 mM Mg
++ 
(MgCl2) 
in 1xPBS 
 
4% w/v PFA 
in bidest H2O pH 7.4 
 
10 mM Tris/HCl pH 7.5 
50 mM KCl 
1.5 mM MgCl2 
 
 
200 mM in DMSO 
 
 
10 mg/mL in PBS 
 
1% Triton X-100 
50 mM Hepes 
150 mM NaCl 
10% Glycerol 
1.5 mM MgCl2 
1 mM EGTA 
10 mM Sodium pyrophosphate 
100 mM NaF 
1 mM Natrium Orthovanadate 
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Running-buffer (10x)  
 
 
 
Sample buffer 2x/4x 
 
 
 
 
 
 
SDS-PAGE-Marker (HMW) 
 
 
 
 
 
 
SDS-PAGE-Marker (LMW) 
 
 
 
 
 
 
Sodium dodecyl sulfat (SDS)  
 
Stacking gel buffer  
 
Storage buffer 
 
 
 
 
TAE-buffer (50x) 
 
 
 
TBS (10x) 
 
 
 
TBS-T 
 
TE-buffer 
 
5 µg/mL Leupeptin 
10 µg/mL Aprotinin 
10 µg/mL Pefablock 
5 µg/mL Pepstatin 
10 µM Benzamidin 
0,1% w/v SDS 
1% v/v Deoxycholin acid 
 
3% w/v Tris Base 
14.4% w/v Glycine 
1% w/v SDS 
 
4% w/v SDS 
20% w/v Glycerol 
125 mM Tris HCL 
10/20% v/v  β-Mercaptoethanol 
1% w/v Bromphenol blue 
pH 6.8 
 
0.5 mg/mL Horseradish-peroxidase (40 kDa) 
0.5 mg/mL Bovine Serum Albumin (66 kDa) 
0.5 mg/mL Lipoxidase (96 kDa) 
0.5 mg/mL  -Galactosidase (116 kDa) 
0.5 mg/mL Myosin rabbit muscle (205 kDa) 
in Triton-buffer 
 
0.5 mg/mL Lysozym (14.4 kDa) 
0.5 mg/mL Soybean Trypsin Inhibitor (22 kDa) 
0.5 mg/mL Horseradish-peroxidase (40 kDa) 
0.5 mg/mL Bovine Serum Albumin (66 kDa) 
0.5 mg/mL Lipoxidase (96 kDa) 
in Triton-buffer 
 
20% w/v SDS 
 
0.5 M Tris Base pH 6.8 
 
0.01 M NaH2PO4 (pH 7.4) 
1% BSA 
0.1% sodium acid 
5% glycerol 
 
500 mM TrisBase 
50 mM EDTA 
5.7% w/v acetic acid 
 
500 mM Tris Base 
1.5 M NaCl 
pH 7.5 
 
0.05% Tween in 1x TBS 
 
10 mM TrisBase 
1 mM EDTA 
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T4 Ligase buffer 
 
 
 
 
Triton-buffer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Western transfer buffer 
 
pH 8.5 (autoclaved) 
 
50 mM Tris/HCl pH 7.5 
10 mM MgCl2 
10 mM Dithiothreitol 
1 mM ATP 
 
1% v/v Triton X-100 
50 mM Hepes 
150 mM NaCl 
10% Glycerol 
1.5 mM MgCl2 
1 mM EGTA 
10 mM Sodium pyrophosphate 
100 mM NaF 
1 mM Sodium Orthovanadat 
5 µg/mL Leupeptin 
10 µg/mL Aprotinin 
10 µg/mL Pefablock 
5 µg/mL Pepstatin 
10 µM Benzamidin 
 
0.3% w/v Tris Base 
1.44% w/v Glycine 
21.5% v/v Methanol 
10% w/v SDS 
30 min devolatilization 
 
 
4.9 Chemicals 
Table 15 Chemicals. 
Name Manufacter 
 
Acetic acid 
 
Aceton 
 
Acrylamid 
 
Agarose 
 
Albumin from chicken egg white 
 
Biotin 
 
Boric Acid 
 
BSA 
 
Calcium chloride 
 
Copper(II) sulfate 
 
 
Roth 
 
Merck 
 
Roth 
 
Roth 
 
Sigma 
 
Thermo Scientific 
 
Merck 
 
AppliChem 
 
Sigma 
 
Merck 
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Ethanol 
 
Ethanolamine 
 
Gelatine 
 
Glycerin 
 
Hydrogen peroxide 
 
Leupeptin 
 
Magnesium chloride 
 
β-Mercaptoethanol 
 
MES 
 
Methanol 
 
mounting Medium 
 
N-(3-Dimethylaminopropyl)-N’-
ethyl-carbodiimide hydrochloride 
 
Sodium Azide 
 
Sodium carbonate 
 
Sodium chloride 
 
Sodium dihydrogen phosphate 
 
Sodium fluoride 
 
Sodium hydrogen carbonate 
 
Sodium hydroxide 
 
Sodium orthovanadate 
 
Sodium pyrophosphate 
 
TEMED 
 
Tris-Base 
 
Triton-X-100 
 
Trypton 
 
Tween-20 
Sigma 
 
Merck 
 
Merck 
 
Roth 
 
Merck 
 
Calbiochem 
 
Roth 
 
Merck 
 
AppliChem 
 
Riedel-de Haën 
 
Dako 
 
Fluka 
 
 
Riedel-de Haën 
 
Riedel-de Haën 
 
Roth 
 
Merck 
 
AppliChem 
 
AppliChem 
 
Riedel-de Haën 
 
AppliChem 
 
AppliChem 
 
Roth 
 
AppliChem 
 
Roth 
 
Roth 
 
Roth 
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4.10 Kits 
Table 16 Kits. 
Name Application Manufacter 
BD BaculoGold
TM
 Transfection Kit 
 
QIAquick Gel Extraction Kit 
 
QIAprep Spin Miniprep Kit 
 
Transfection of Sf9 cells 
 
Gel Extraction 
 
Plasmid isolation 
BD Biosciences 
 
Qiagen 
 
Qiagen 
 
4.11 Equipment 
Table 17 Equipment. 
Name Notation Manufacter 
Autoclave 
 
 
Balance 
 
 
Blotter 
 
 
Centrifuges 
 
 
Digestor 
 
Electrophoresis System 
(agarose power supply) 
 
Electrophoresis System 
(SDS) 
 
Gel Documentation 
 
Incubator (bacteria) 
 
Incubator (cells) 
 
Microscopes 
 
 
 
Microwave 
 
Mini UV Table 
 
Neubauer Chamber 
 
PCR Cycler 
 
pH Meter 
Autoclave 
 
 
Kern 440-47N / Kern 440-
35N 
 
Perfect Blue Semi-Dry 
Elektroblotter 
 
5415R / 5417R / 5702 
Multifuge 1s-R 
 
Dry-block DB-3 
 
EV343 / E132 / EV202 
 
 
Mini Protean 3Cell 
 
 
GelDoc XR System  
 
Celsius 2005 
 
Innova Co 170 CO2  
 
ECLIPSE TS100  
 
AF 6000LX  
  
646223M  
 
60 ECX 20M  
 
Neubauer Chamber 
 
Primus 25 advanced 
 
Seven Easy 
Sauter, Sulgen Switzerland 
A.Hartenstein 
 
PeqLab 
 
 
Eppendorf 
 
 
Hereaus Instruments 
 
 
Techne 
 
Consort 
 
 
BioRad 
 
 
BioRad 
 
Memmert 
 
New Brunswick Scientific 
 
Nikon 
 
Leica 
 
Privileg 
 
PeqLab 
 
Roth 
 
PeqLab 
 
Mettler Toledo 
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Rotator 
 
Spectrophotometer 
 
Spectrofluorometer 
 
X-ray Cassette  
 
SB 3 
 
NanoDrop ND-1000 
 
Varioskan Flash 
 
Stuart 
 
PeqLab 
 
Thermo Scientific 
 
Rego 
 
4.12 Material 
Table 18 Material. 
Product Supplier 
Plastic Ware  
 
Cover Slips  
 
Eppendorf tubes  
 
Glass Ware  
 
Object Slides 
 
Pipettes  
 
Pipettes Tips 
 
PVDF-Membranes  
 
Sterile Filter (Poresize: 0.2 µm & 0.45 μm)  
 
X-Ray Films  
 
Greiner Bio-one 
 
WTC Binder 
 
Eppendorf 
 
Schott 
 
Menzel Gläser 
 
Gilson 
 
Sarstedt 
 
Millipore 
 
Schleicher & Schuell 
 
Typon Imaging AG 
 
4.13 Software 
Adobe Photoshop 6.0, Bio Edit, Clone Manager Professional 9, ImageJ, LAS 
software, MS Office and Quantity One. 
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5. Methods 
5.1 Methods with cells  
 5.1.1 Culturing 
Sf9 cells were cultured in 10 cm dishes with pre-warmed Sf9 medium and kept in 
water saturated atmosphere at 27ºC. Cells were splitted every two to three days, normally 1:3, 
scratching the cells, resuspend them in the dish and transferred them to a sterile 15 mL tube. 
Cells were centrifuged 3 min at 800 rpm, the old medium was aspired and new medium was 
added. The cells were then seeded with the appropriate dilution. 
Raw 264.7 cells were cultured in 10 cm dishes with pre-warmed medium and kept in 
water saturated 95% air / 5% CO2 atmosphere at 37 ºC. Cells were splitted every two to three 
days, normally 1:5, scratching the cells, resuspend them in the dish and transferred them to a 
sterile 15 mL tube. Cells were centrifuged 3 min at 800 rpm, the old medium was aspired and 
new medium was added. The cells were then seeded with the appropriate dilution. To analyze 
the cells by staining in slides, the plates needed to be coated. Coverslips and 500 µL of 0.1 % 
Gelatine per well were added to the plate and incubated for 2 hours at 37 ºC. After this time 
the Gelatine was aspired and the cells were seeded. 
HEK 293T cells were cultured in 10 cm dishes with DMEM + 7.5% v/v CS and kept 
in water saturated 95% air / 5% CO2 atmosphere at 37ºC. Cells were splitted every two to 
three days, normally 1:5, adding 5 mL of PBS to wash them, after aspiring the medium, and 1 
mL of Trypsin EDTA, after aspiring the PBS, until the cells were detached. The reaction of 
Trypsin is stopped by adding 4 mL of fresh medium. The cells were resuspended and then 
centrifuged, in a clean sterile 15 mL tube, 3 min at 800 rpm. The medium was aspired and 
new medium was added. Cells were seeded using the desired dilution. 
 
5.1.2 Unfreezing and refreezing of cells 
To unfreeze one vial of cells was removed from liquid nitrogen. The vial was thawed 
in a 37 ºC water bath. After thawing, the entire vial was sprayed with 70% EtOH. The cells in 
the vial were gently suspended and transferred to a sterile 15 mL tube. 5 mL of pre-warmed 
medium were added slowly and the cells were centrifuged for 3 min at 600 rpm. The 
supernatant was aspired and the pellet was resuspended in 10 mL of fresh medium. The 
suspension was transferred to a 10 cm dish and the cells were incubated in the appropriate 
atmosphere. 
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Only well growing cells with good viability and low passaging number were used for 
freezing. The cells were harvested and centrifuged. The pellet was resuspended in 1 mL of 
specific medium and transferred to a sterile cryovial. The cryovial was transferred to an 
Isopropanol box and stored at -80 ºC to allow slow freezing. After 24-72 hours, cells were 
transferred to liquid nitrogen storage. 
 
 5.1.3 Counting of cells 
If necessary for the experiment, cells were counted before seeding into well-
plates/dishes. After transferring the cells to a sterile 15 mL tube, 10 µL of the suspension were 
added to a Neubauer chamber (Figure 34). 
  
The cells in the blue squares (Figure 34) were counted and the total 
number was multiplied by 1 x 10
4
 to receive the concentration of cells per 
mL. 
 
 5.1.4 Transfection of Sf9 cells 
A clean plasmid preparation was needed for each transfection sample. 7x10
5
 cells/mL 
were seeded in each dish (3.5 cm dishes). The cells were incubated at 27ºC until they stick to 
the dish (≥15 min). One negative control was used to compare transfected cells. In the 
meantime, 2 µL of BaculoGold DNA was combined with 1 µg of the plasmid DNA in a clean 
sterile tube and mixed. After 5 min, 0.4 mL of the Transfection Buffer B were added. The 
medium in the dish with the attached cells was aspired and 0.4 mL of the Transfection Buffer 
A were added. The sample in tube was added to the dish dropwise and mixed. The dishes 
were incubated at 27ºC for 4 h. After that time the supernatant was aspired and the cells were 
washed in 1.5 mL of fresh medium and were kept with 1.5 mL of fresh medium in the 
appropriate atmosphere for 5 days. 
After 5 days, the cells were collected and centrifuged (2000xg, 5 min). The 
supernatant was then transferred to another clean sterile tube and stored at 4 ºC. 
Transfection supernatants should be amplified to produce high titer virus stocks that 
are used for recombinant protein production. 
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 5.1.5 Transfection of HEK 293T cells 
One day before transfection, the cells were seeded with low density in 10 cm dishes. 
First 500 µL of sterile H2O were added to a 14 mL tube and 5 µg of appropriate plasmid DNA 
were added. 500 µL of 2x HBS-Buffer were added to the mixture and mixed by vortexing. 50 
µL of sterile 2.5 M CaCl2 were added dropwise while vortexing the tube. The samples were 
incubated 15 min at room temperature to allow DNA precipitation. Meanwhile, 10 µL of 
chloroquine (25 mM) were added to the cells. After the incubation time, 1 mL of DNA from 
the tubes was added to the cells, drop by drop and the dishes were incubated 6-8 hours at 
37ºC. After this time, the medium was aspired and new medium was added to the cells. The 
cells were then incubated 2 days at 37 ºC.  
 
5.2 Recombinant protein expression with BEVS 
5.2.1 Amplification of Baculovirus 
For each amplification MOI 1 was used. The volume of the needed virus supernatant 
to infect the cells was calculated as follows: 
, where C is the virus titer and n is the number of the cells in the dish. 
 If the virus titer was unknown (transfection supernatants), the cells were infected with 
200 µL. In this case the number of the cells in each 10 cm dish was 8,8x10
6
. 
5x10
6
 cells were seeded in one 10 cm dish and the cells were kept in the appropriate 
environment until they were attached to the dish. After this time, the cells were infected with 
the virus and incubated at 27ºC during 5 days. 
 After 5 days, the supernatant was collected by centrifuge the culture medium in the 
dish 5 min at 2000 x g. The supernatant was stored at 4ºC. 
To determine the titer of the virus, cells were seeded in a 96 well-plate (2.5x10
5
 
cells/mL in each well) and, after they were attached, the cells were infected with different 
dilutions of the virus in duplicate. Normally, the dilutions used were 10
-2
, 10
-3
, 10
-4
 and 10
-5
. 
The well-plate was incubated at 27ºC during 2 days and then the cells were analyzed by 
fluorescence microscopy after antibody staining. 
 
5.2.2 Expression of the protein 
Initially the time of expression for each protein had to be determined. 2.5x10
6
 cells 
were seeded in 6 cm dishes and transduced with the virus concentrate carrying the appropriate 
construct at MOI 4. One negative control was used (without infection) and for each construct 
65 
 
3 dishes were infected (24, 48 and 72 hours). The cells were then incubated at 27ºC. After the 
24 h the negative control dishes and the 24 hours dishes were removed from the incubator and 
the cells were counted. The lysis was done with 2xSDS buffer or Sf9 lysis buffer. The cells 
were centrifuged 3 min at 800 rpm and the supernatant was aspired. The sample with lower 
cell number was resuspended in 100 µL of 2x SDS buffer. In the other sample the addition of 
2x SDS buffer needed to be in the same proportion of the number of cells. The samples were 
boiled 5-10 min and stored at -20 ºC until analysis. In the next days the procedure was the 
same but the addition of 2x SDS was related to the 100 µL added in the first day. The samples 
were then analyzed by western blot for target protein expression. 
After determination of the best expression time, the cells were seeded in 10 cm dishes 
(10 dishes for each expression). The number of cells seeded was 8.8x10
6
 per dish. Each dish 
was infected with the virus concentrate at MOI 4 and then the cells were incubated at 27ºC. 
 
 5.2.3 Sf9 Lysis 
The transduced cells were harvested, counted and the total cell number was calculated. 
The cell suspension was centrifuged (5 min at 800 rpm), the supernatant was aspired and the 
pellet was resuspended in lysis buffer (1 mL lysis buffer / 2x10
7
 cells). The lysate was 
incubated for 20 min at 4ºC under constant rotation and then centrifuged 30 min at 13000 rpm 
at 4ºC (Thermo centrifuge, Rotor SS34). The supernatant was transferred to clean Eppendorf 
tubes and stored at -80ºC (after shock freezing with liquid nitrogen) for long-term storage or 
at -20ºC for overnight storage. 
 
 5.2.4 Purification of the protein  
For all proteins was used FPLC (Fast protein liquid chromatography) technique. Two 
different columns were used. For the His column, the column was washed with 50 mM NaPi 
(pH 8) and 1 M NaCl after addition of the protein. This connects the protein to the niquel that 
stay stacked to the membrane in the column. After this, starts the second washing step with 
0.5 M Imidazol, 0.5 M NaCl and 50 mM NaH2PO4.H2O. This separate the protein of the 
niquel and the protein was collected in glass tubes. The same was made for GST column, with 
50 mM Tris pH 8 and 10 mM GSH to wash the column. 
4 kDa dialysis membranes were swelled in ddH2O and the fractions with the protein 
were added to the membrane. Dialyis was performed 4x each one with a new basin during 1.5 
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-3 hours (the last one was always made over night). In the final dialysis step the buffer was 
supplemented with 10% Glycerin. All steps were performed at 4ºC under mixing. 
The protein was collected from the dialysis membrane and aliquoted in clean 1.5 mL 
Eppendorf tubes. The protein was shock-freezed in liquid nitrogen and stored at -80ºC. 
 
5.3 Microscopy 
 5.3.1 Staining of Sf9 cells 
The cells were washed 3x with PBS
++
 (100 µL/well) and then fixed for 15 min with 
4% PFA. Then the cells were washed 1x with PBS
++
 and permeabilized for 5 min with 0.5% 
Triton X-100 in PBS. Again the cells were washed 1x with PBS
++
 and blocked for 10 min. 
The first antibody was added (α-NEF 1:250 in blocking solution) and the well-plate was 
incubated for 45 min at room temperature in the dark. After this time the cells were washed 
2x with PBS
++
 and blocked again for 10 min. The second antibody was added (α-Mouse IgG-
Cy3 1:300 in blocking solution) and the well-plate was incubated for 45 min at room 
temperature in the dark. The cells were washed 2x with PBS
++
 and incubated for 15 min with 
Hoechst (1:10000 in PBS
++
) at room temperature in the dark. The cells were washed 2x with 
PBS
++
 and then stored at 4ºC in PBS
++
 until analysis.  
 
5.3.2 Baculovirus Titer determination 
The baculovirus titer was determined by staining of infected Sf9 cells for target 
protein expression and subsequent analysis by fluorescence microscopy. The properties of the 
channels were adjusted to the controls and then the dilution was chosen for quantification 
with less than 10% of infected cells. Three images were taken for each well and the total cell 
number in each image was determined as well as the infected cells only. The titer was 
calculated as shown below. 
, where M1 is the number of uninfected cells and M2 is the number of 
infected cells. 
 
The MOI was calculated for each well and then the mean MOI was used to calculate 
the titer of the virus as described below. 
dilution
MOI
pfuTiter
5102
)(

 , and the result come in mL-1. 
To amplification was repeated until a titer of 2x10
8 
pfu/mL was reached. 
 







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 5.3.3 Staining of Raw 264.7 and HEK 293T cells 
The cells were washed 3x with PBS
++
 and fixed for 15 min at room temperature with 
4% PFA. After this time, the cells were washed again 3x with PBS
++
 and permeabilized for 3 
min with 0.4% Triton X-100 in PBS (if the procedure was only for staining of the 
extracellular particles the cells were not permeabilized). The cells were washed again 3x with 
PBS
++
 and incubated for 10 min with blocking solution. After this time, the blocking solution 
was aspired and 25 µL of the first antibody was added to each well (1:100 – 1:400 in blocking 
solution). The well-plate was incubated for 1 h at room temperature in camera humidified 
box. After this incubation time, the cells were washed 3x with PBS
++
 and blocked again for 10 
min. The second antibody was added (1:100 – 1:200 in blocking solution) and the well-plate 
was again incubated in the humidified box for 45 min at room temperature. Finally, the cells 
were washed 3x with PBS
++
. 
 
5.3.4 Staining of the beads 
For direct labeling of the protein-coated polystyrene beads, the beads were incubated 
for 30 min at 37ºC under constant shaking with CFSE 1:1000 in PBS. Afterwards, the beads 
were washed three times with PBS to remove residual CFSE. After each washing step the 
beads were centrifuged at 1000xg for 1 min and the supernatant was discarded. 
To stain the extracellular beads in the cells, after fix them, some protein don’t have an 
antibody, as for Albumin as example. Thus, for the intra and extracellular assay, the beads 
were biotinilated with Sulfo-NHS-LC-Biotin (Thermo Scientific), 0.5 mg/mL in PBS, during 
staining with CFSE. 
 
5.4 Molecular-biological methods 
 5.4.1 Polymerase chain reaction (PCR) 
All PCRs were performed under “hot-start” conditions. A typical sample recipe is 
described in Table 19. 
 
Table 19 Typical recipe for PCR. 
Reaction mix Enzyme mix 
H2O                 32 µL H2O                 8 µL 
10xBuffer (+ MgCl2)                 4 µL 10xBuffer (+ MgCl2)               1 µL 
Primer 1 (5’)                1 µL (10 pM) Pfu-Polymerase                          0.5 µL 
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Primer 2 (3’)                          1 µL (10 pM) Taq-Polymerase              0.5 µL 
Template             1 µL (~100 ng) Total               10 µL 
dNTPs               1 µL (20 mM)  
 
Total                 40 µL 
 
Reaction and Enzyme mix were always prepared separately. The program of the PCR 
was conducted as described in Table 20. 
 
Table 20 PCR program. 
1. Heat Lid to 110ºC. 
2. Initial denaturation of the template DNA: 94ºC for 1 min. 
3. Pause at 94ºC (addition of the enzyme mix to the reaction mix). 
4. Start Loop, 34x. 
5. Denaturation of the DNA: 94ºC for 15 seconds.  
6. Annealing: 50 ºC – 65 ºC for 25 seconds (depending on the melting temperature of the 
used primers. Generally, an annealing temperature of about 6°C below the melting 
temperature was used) 
7. Elongation: 72ºC for 1 min – 2 min per  1kb. 
8. Close Loop. 
9. Final elongation: 72ºC for 8 min.  
10. Store forever at 8ºC (until further processing). 
 
5.4.2 Agarose Gel-Electrophoresis 
Depending on the size of the analyzed DNA gels with a agarose concentration between 
0.7% and 2% were used. A 0.7% gel will show good separation (resolution) of large DNA 
fragments (5–10 kb) and a 2% gel will show good resolution for small fragments (0.2–1kb). 
Typically, a band is easily visible if it contains about 20 ng of DNA, depending on the number 
and size of the bands expected. The suitable amount of agarose was solved in 1x TAE buffer 
by heating and poured into the gel chamber after cooling down to about 50°C. Slots were 
formed by a comb. The DNA samples were mixed with 6x GEBS, applied to the slots and 
then separated in 1x TAE at 90 V (for analytical gels) or 60 V (for preparative gels). A DNA 
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standard (Gene Ruler DNA Ladder) that was also applied in one slot facilitated a direct 
comparison of the fragment sizes. DNA bands were visualized by staining the gel in an 
ethidium-bromide (EtBr) bath (10 min), as after intercalation into the DNA, EtBr fluoresces 
under UV light. 
 
 5.4.3 Recovery of DNA from agarose gels (Gel extraction) 
The band of interest was visualized by ethidium bromide staining on a UV light-box (a 
trans-illuminator). As the UV mutagenizes the DNA at a measurable rate, the time that the gel 
was exposed at UV light was kept at a minimum. A scalpel blade was used to cut out the band 
of interest and the fragment was placed in a clean 1.5 mL Eppendorf tube. The DNA was 
purified with the help of a kit (QIAquick gel extraction/PCR purification) according to the 
manufactures instructions.  
 
5.4.4 PCR-Products purification 
The PCR fragments were purified with the help of a kit (QIAquick gel extraction/PCR 
purification) according to the manufactures instructions.  
 
 5.4.5 Restriction digest of DNA 
Depending on the restriction sites appropriate restriction enzymes and buffers were 
used. A typical recipe used in this procedure is described in Table 21. 
 
Table 21 Typical recipe for DNA digestion. 
 
DNA                  3 µg 
Buffer (10x)                              1 µL 
Restriction enzyme 1                             1 µL  
Restriction enzyme 2                 1 µL 
H2O                                  dependent 
Total                             10 µL 
 
If necessary, the samples were supplemented with 100 µg/mL BSA. Depending on the 
total volume of the recipe the volume of buffer was adapted. The volume of the enzyme used 
depended on the time of digestion, the amount of DNA and the efficiency of the enzyme in 
70 
 
the used buffer. Typically, the time of digestion was 3 h at 37ºC. If the time of digestion was 
over night the amount of used enzyme was normally 0.3 µL. The digestion fragments were 
analyzed by agarose gel electrophoresis after purification with the help of a kit (QIAquick gel 
extraction/PCR purification). 
 
 5.4.6 Quantification of nucleic acids 
Quantification of DNA was conducted by a spectrophotometer (NanoDrop) using 1.2 
µL of the sample. Sample buffer only was used for blank measurement.  
 
 5.4.7 Dephosphorylation of DNA fragments with alkaline phosphatase  
To dephosphorylate the 5´-positions of the backbone DNA, the samples were treated 
by alkaline phosphatase. A typical recipe used is described in Table 22. 
 
Table 22 Typical recipe for alkaline phosphatase treatment. 
 
Phosphatase Buffer (10x)       depending 
Alkaline Phosphatase                             1 µL 
Volume of digestion                   All  
 
The samples were mixed and kept for 15 min at 37 ºC and then heat inactivated at 
65ºC for 10 minutes. 
 
 5.4.8 Ligation of prepared vectors and DNA fragments 
The digested and dephosphorylated backbone DNA (vector) as well as the digested 
cDNA insert were ligated using T4 Ligase. In all the experiments 10 and 40 fmol of vector 
and insert, respectively, were used. A typical recipe used is presented in Table 23.  
 
Table 23 Typical recipe for ligation. 
 
Vector              10 fmol 
Insert                                      40 fmol 
T4 Ligase                              1 µL  
T4 Ligase Buffer (10x)                 1 µL 
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H2O                                  dependent 
Total                             10 µL 
 
As a negative control always a ligation sample was made with the vector only. After 
adding all the volumes to clean 1.5 mL Eppendorf tube, the samples were kept for 30 min at 
room temperature. If the ligation was made over night, the samples were kept at 4ºC. 
Afterwards, the ligation samples were transformed in E. coli Nova Blue.  
 
 5.4.9 Transformation 
100 µL of chemically competent cells (Nova Blue) were added to 14 mL tubes (one 
tube for each sample) and the plasmid DNA to be transformed was added to the competent 
cells. The tubes were incubated on ice for 30 min and then heat shocked for 75 seconds at 
42ºC. 1 mL of LB medium was added to each tube and they were incubated for 1 hour at 37 
ºC under constant rotation (225 rpm). After this time, the whole volume in each tube was 
transferred to a clean Eppendorf tube and centrifuged at 3000 rpm for 3 min. The supernatant 
was discarded with exception of about 100 µL and the pellet was resuspended in the left 
supernatant. This volume was plated on an agar plate with the appropriate selection antibiotic 
(depending on the resistance of the transformed plasmids). The plates were then incubated at 
37ºC over night. 
 
5.4.10 Preparation of Plasmid DNA (Mini-prep) 
 Plasmid isolation from E. coli was conducted as described in Table 24.  
 
Table 24 Isolation of Plasmid DNA. 
1. The bacteria were scratched from the plate and suspended in 300 µL of buffer P1.  
2. 300 µL of buffer P2 were added and the tubes were inverted 10 times. 
3. 300 µL of buffer P3 were added and the tubes were inverted 10 times. 
4. The samples were centrifuged for 10 min at 4 ºC (14000 rpm). 
5. The supernatant was transferred to clean eppendord tubes and the pellet was discarded. To 
each sample 560 µL of isopropanol were added and the tubes were inverted three times. 
6. Centrifuge for 15 min. 
7. The supernatant from this centrifugation was aspired. The pellets were washed with 500 µL of 
EtOH each and centrifuged again for 5 min. 
8. The supernatant was aspired again and a new centrifugation took place during 2 min. 
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9. The pellet was then incubated 20 min at 37 ºC (to dry the left EtOH). 
10. After this time, the pellet was resuspended in 40 µL of TE Buffer. 
 
 5.4.11 DNA Sequencing 
For sequencing, 2 µg of Plasmid DNA were added to a clean Eppendorf tube and 
sterile H2O was added to a total volume of 30 µL. Samples were sent to GATC, Konstanz and 
the obtained sequence was compared afterwards with the aid of the clone manager. 
 
5.5 Protein-biochemical analysis 
 5.5.1 SDS-Polyacrylamide gel-electrophoresis (PAGE) 
The concentration of acrylamide determines the resolution of the gel - the greater the 
acrylamide concentration so much the better the resolution of lower molecular weight 
proteins. The lower the acrylamide concentration so much the better is the resolution of higher 
molecular weight proteins. Depending on the size of the protein of interest different 
concentrations of acrylamide were used. 
The gel used for protein separation was prepared in two steps: the separating gel was prepared 
first and added into the space occupied by the cassettes, overlayed with ddH2O and left by 20 
min until it get polymerized. The second gel, the stacking gel, was added into the left space 
between the cassettes and the teeth were added into this gel. 20 more minutes were needed 
until the gel get polymerized. The samples were mixed with 2x SDS-buffer and were boiled 
together with a protein standard for 5-10 min at 95°C. The samples and the protein standard 
were loaded onto the gel and the separation was conducted at 120 V for 2 h. A typical recipe 
of the gel is presented in Table 25. 
 
Table 25 Typical recipe for preparation of a SDS-PAGE gel. 
 
Separation gel (12.5 %) 
 
 
 
 
Stacking gel (5 %) 
 
 
 
 
Running buffer 
 
4.3 mL dH2O; 2.5 mL Tris (1,5 M; pH 8,8); 3.1 mL 
Acrylamide (40%); 50 μL Sodium dodecyl sulfate (SDS; 
20%); 30 μL Ammonium Persulfate (APS; 10%); 15 μL 
TEMED 
 
6.15 mL dH2O; 2,5 mL Tris (0,5 M; pH 6,8); 1.25 mL 
Acrylamide (40%); 50 μL Sodium dodecyl sulfate (SDS; 
20%); 30 μL Ammonium Persulfate (APS; 10%); 15 μL 
TEMED 
 
25 mM Tris-HCl; 192 mM Glycine; 0.1% SDS; 2 L dH2O 
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 5.5.2 Western Blot (Semy-Dry) 
For Western Blots, PVDF membranes were used which were activated in Methanol 
first and than rinsed in Anode buffer. Three filter papers were wetted in Anode buffer and put 
in the Semy-Dry Blotting chamber. After adding the pre-activated membrane, the gel which 
was rinsed in Cathode buffer was put on top. Finally, three filter papers were added which 
were wetted in Cathode buffer before. The transfer was conducted at 75 mA per membrane 
for 2 hours. After this time, the membrane was stained with Coomassie blue and de-stained 
afterwards. The bands of the protein standard were marked on the membrane with an usual 
pen. After this, of the membrane was washed once in TBS-T and than it was incubated in 
blocking solution for 1 h at room temperature to prevent non-specific antibody binding in the 
following steps. After blocking, the membrane was incubated with the primary antibody 
(generally between 0.5 and 5 μg/mL in blocking solution) at 4°C over night.   
After washing the membrane three times with TBS-T to remove unbound and non-
specific bound primary antibody, the membrane was exposed to another antibody, directed at 
a species-specific portion of the primary antibody. The secondary antibody was diluted 
1:3000 in TBS-T. It is usually linked to biotin or to a reporter enzyme such as alkaline 
phosphatase or horseradish peroxidase. This means that several secondary antibodies will 
bind to one primary antibody and enhance the signal. Usually the secondary antibody was 
incubated with the membrane for 1 hour at room temperature. After this time the membrane 
was washed three times with TBS-T and incubated for 2 min with 10 mL of ECL-medium and 
3 µL of 35% H2O2. The membrane was then closed into an X-ray cassette and developed in a 
darkroom using a AGFA Curix60. 
 
 5.5.3 Cell Lysis 
  All steps were performed at 4°C. The culture medium was discarded and PBS was 
added to wash the cells. The PBS was then aspired, taking care to not aspire the cells, and 1 
mL of RIPA buffer was added. The cells were maintained 2-5 min in this buffer and were 
scratched from the dish. The lysates were then transferred to clean Eppendorf tubes. To break 
the DNA, the lysates were passed 6-10 times through a fine needle using a syringe. After this, 
50 µL of sepharose beads were added to the tubes and get mixed. The tubes were left 5 min in 
the shaker and centrifuged for 10 min at 13000 rpm and 4ºC. The supernatant from the 
centrifugation step was collected to a new tube and the lysate was stored at -80ºC.  
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 5.5.4 Protein concentration determination 
 To determine the concentration of purified proteins a SDS-PAGE procedure was used. 
The samples with unknown protein concentration were added to the gel with samples with 
known concentration (usually BSA in different concentrations). After coomassie staining and 
de-staining of the gel the band of the protein was compared to the bands of BSA and the 
closest match was used to calculate the concentration of the purified protein. Alternatively, 
the concentration was determined with a spectrophotometer (NanoDrop) against an 
appropriate blank.  
 
5.6 In Vitro Kinase Assay 
In this assay, two substrates were used, GST-p130
Cas
 and GST-FAK. The adaptor 
protein p130
Cas
 (Cas) has been shown to be involved in different cellular processes including 
cell adhesion, migration and transformation. This protein has a substrate domain with up to 15 
tyrosines that are potential kinase substrates, able to serve as docking sites for proteins with 
SH2 or PTB domains. Cas function is dependent on tyrosine phosphorylation of its substrate 
domain and can be used to study the activity of kinases in vitro. This substrate was already 
shown to be useful to test the kinase activity of FAK [Cas as substrate]. The C-terminal part 
of substrate domain of this substrate is from rat p130
Cas
 (a.a. S
325
 to R
516
). FAK can also be 
phosphorylated by other kinases, being useful to study the kinase activity in vitro. This 
substrate is a peptide around autophosphorylation site of human FAK (a.a. N
378
 to T
406
). 
In clean Eppendorfs were added the kinase, the substrate and the ATP, dependent from 
the control to the kinase buffer. The samples were then incubated 30 min at 30ºC. In the 
meantime, Glutathione beads were washed three times at 2500xg, 1 min each wash, at 4ºC in 
PBS and resuspended afterwards in kinase buffer. After the incubation time, the samples with 
GST-FAK substrate were mixed with 2xSDS buffer 1:2 and stored at -20ºC. The samples with 
GST-p130
cas
 substrate were mixed with Glutathione beads 1:2 after stopping the kinase 
activity with 1 mM EDTA, and incubated 1 h at 4ºC under constant rotation. After this time, 
the samples were centrifuged and the supernatant was transferred to new Eppendorf tubes and 
mixed with 2xSDS buffer 1:2. The beads were then washed three times with PBS, 
resuspended in kinase buffer and mixed with 2xSDS buffer 1:2. All samples were then boiled 
at 95ºC and loaded onto a 12.5% SDS gel, and run at 120 V. The gel was then transferred to a 
membrane by Semi-Dry Western blotting. The antibodies used in this assay were the 
75 
 
Phospho-Tyrosine to detect the phosphorylation of the kinase and the substrate, the GST to 
detect the substrates and NEF to detect the kinases. 
  
5.7 Covalent coupling of proteins to latex beads 
For each protein to be coupled, 200 μl of a 2.5% solution of carboxylated polybead 2 
µm microspheres (in short: latex beads) were added to a 2 mL Eppendorf tube with 1 mL of 
carbonate buffer. The beads were mixed with this buffer and then centrifuged for 6 minutes at 
10000 rpm. The supernatant was discarded and the latex beads were resuspended in 1 mL of 
carbonate buffer and washed again. After this step, the latex beads were washed four times 
with 1 mL of MES buffer. After the fourth washing step the beads were resuspended in 0.625 
mL MES buffer and 0.625 mL of a freshly prepared 2% carbodiimide solution were added, 
drop by drop. The latex beads were then kept, at a maximum of 4 h, on a rotor at room 
temperature, under constant inverting. After this time, the latex beads were centrifuged. The 
supernatant was discarded and the beads were washed three times with 1 mL MES buffer. 
Thereafter, the latex beads were resuspended in 600 μL of borate buffer and 200-400 μg of 
protein to be coupled were added. The beads were then incubated on the rotor at room 
temperature over night. 
In the next day, 25 μL of ethanolamine solution were added and the bead solution 
remained inverting for 30 minutes on the rotor. This way, the latex beads which have not 
reacted with the protein to be coupled will be blocked. Thereafter, the latex beads were 
centrifuged for 10 minutes and resuspended in 1 mL of borate buffer with 1 mg/mL BSA and 
incubated for 30 minutes at room temperature on the rotor. The latex beads were washed once 
with 1 mg/mL BSA in borate buffer and then resuspended in 200 µL of storage buffer. 
To control if the coupling worked, 10 µL of the beads were added to a clean 
Eppendorf tube and washed 3x with PBS-T. After these washing steps, the beads were stained 
for the proteins that were coupled and the fluorescence intensity was measured with a 
spectrofluorometer.  
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